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Abstract 
 
Streptococcal pathogens, particularly Streptococcus iniae, are emerging as a major cause 
of meningitis and septicaemia in a broad range of farmed and wild fish species, and are 
occasionally zoonotic. The major virulence factor in fish pathogenic streptococci is a highly 
variable antigenic polysaccharide capsule, which has resulted in serotype switching and 
reinfection of previously vaccinated fish. Therefore there is an urgent need to investigate 
more highly conserved protein-based critical virulence factors as targets for new vaccines. 
Complement proteases C5a peptidase and C3 protease of S. iniae were investigated in 
the present study to determine their role in virulence, as they are both secreted or surface 
associated and may represent potential targets for vaccination. My research shows that 
the C5a peptidase (scpI) and C3 protease (cppA) are inversely regulated with capsular 
polysaccharide. This coordinate regulation allows the capsule to be down-regulated to 
permit attachment to hydrophobic surfaces which may be essential for invasion of the 
Central Nervous System (CNS) and rapid onset of meningitis, whilst the proteases are up-
regulated to protect the bacteria from complement-enhanced killing by neutrophils in 
barramundi whole blood assays. Knockout mutants deficient in each of the genes revealed 
reduced growth in whole blood, serum and antiserum. Moreover, these mutants revealed a 
role for ScpI and CppA in the interruption of the classical pathway since they were 
susceptible to the antiserum, which contained specific antibodies and complement proteins 
activating the classical pathway. Additional work to determine whether blood and serum 
resistance can be rescued by complementing the knockout mutants is required. To explore 
environmental factors in the host that may drive coordinate regulation of scpI and cppA 
with capsular polysaccharide synthesis protein E (cpsE) iron limitation was investigated. 
Iron stress appeared to be as one of the triggers for reduction the expression of capsule 
and coordinate increase in complement proteases expression. Future work should 
elucidate further environmental cues in the host that regulate expression of these genes, 
as it is likely to be complex and multifactorial. Together, these data implicate complement 
proteases in survival and dissemination in the host and therefore warrant further 
investigation as conserved protein targets for vaccines for farmed fish. 
 
 
! !
 
Declaration by author 
 
This thesis is composed of my original work, and contains no material previously published 
or written by another person except where due reference has been made in the text. I 
have clearly stated the contribution by others to jointly-authored works that I have included 
in my thesis. 
 
I have clearly stated the contribution of others to my thesis as a whole, including statistical 
assistance, survey design, data analysis, significant technical procedures, professional 
editorial advice, and any other original research work used or reported in my thesis. The 
content of my thesis is the result of work I have carried out since the commencement of 
my research higher degree candidature and does not include a substantial part of work 
that has been submitted to qualify for the award of any other degree or diploma in any 
university or other tertiary institution. I have clearly stated which parts of my thesis, if any, 
have been submitted to qualify for another award. 
 
I acknowledge that an electronic copy of my thesis must be lodged with the University 
Library and, subject to the policy and procedures of The University of Queensland, the 
thesis be made available for research and study in accordance with the Copyright Act 
1968 unless a period of embargo has been approved by the Dean of the Graduate School.  
 
I acknowledge that copyright of all material contained in my thesis resides with the 
copyright holder(s) of that material. Where appropriate I have obtained copyright 
permission from the copyright holder to reproduce material in this thesis. 
 
 
! !
 
Publications during candidature 
 
Submitted paper 
Chan N. Dieu, Andrew C. Barnes. Coordinate inverse regulation of putative complement-
degrading proteases scpI and cppA with capsule in fish pathogenic Streptococcus iniae. 
Veterinary Microbiology (2015). 
  
Publications included in this thesis 
 
No publications included. 
 
Contributions by others to the thesis  
 
Associate Professor Andrew C. Barnes provided substantial intellectual support, 
supervision, funding, critical revision of entire thesis, and bioinformatics in Chapter II. 
 
Mr. Michael Nefedov (School of Chemistry & Molecular Biosciences) provided assistance 
with Real-time PCR method and design. 
 
Dr. Candice M. Health provided trouble shooting for making knock out mutants, and 
prepared the competent cells for electroporation described in Chapter III. 
 
Dr. Gay Marsden provided general editing of thesis. 
 
Statement of parts of the thesis submitted to qualify for the award of another degree 
 
None. 
 
 
 
 
 
! !
 
Acknowledgements 
 
Heading to Brisbane rather than Berlin was such a tough decision I had made ever, and it 
still confused me during the first month after arrival. It looked like I closed all the doors 
leading to human relating research to jump into a complete new field, the fish! Today, 
settling down and looking back the past two years I have spent here, that decision is worth 
in every single aspect. Though there were many experiences and obstacles during the 
time of doing my MPhil candidature, this was a splendid time for me to perceive challenges 
and also seduction from the marine biotechnology field. Therefore, it is the time and my 
pleasure to send a big thank to many people presenting in my MPhil adventure! 
 
In the first honor place, I would like to send the greatest appreciation to my supervisor 
Andy Barnes, who has encouraged and supported me to go over the course. His 
intellectual support is definitely critical to make this thesis possible.  
 
A very big hug to Gay Marsden, who has encouraged me jump into the pool! Thanks to her 
taking care of me in the first few months I’ve been here, and always checking whether I’m 
ok or not even she is working abroad.   
 
Thanks to my entire lab mates who contributed this thesis with either intellectual or spirit 
supports. To Candice who introduced me to the world of knock out mutant, and kept 
encouraging me practicing my presentation skill. Thanks for her trouble shooting to not 
only knock out stuffs, but also others lab stuffs. To Kelly-Anne who always gives a satisfied 
answer to my every single question, she is also the one encouraged me purchase the first 
tennis racquet in my life! To Emma, Minami, Alex, and Jerome those helped me with the 
aquarium duties. 
 
Lastly, I would like to thank to my family those live far away but always be in my heart. To 
my parents who have taken good care of me for 27 years since I was born, and keep 
doing it for another 27 years plus and plus. I know I am always their child even I’m getting 
mature now. I can’t wait to see them in my graduation ceremony this July! Last but not 
least, to my fiancé Phong Phan, ‘my cc’, thanks for his love, patience, and waiting for me. 
 
 
 
! !
 
Keywords 
 
Streptococcus iniae, complement, capsule, C3 protease, C5a peptidase, ΔscpI, ΔcppA. 
 
Australian and New Zealand Standard Research Classifications (ANZSRC) 
 
ANZSRC code: 060405, Gene Expression, 40% 
ANZSRC code: 060501, Bacteriology, 40% 
ANZSRC code: 060804, Animal Immunology, 20% 
 
Fields of Research (FoR) Classification 
 
FoR code: 0604, Genetics, 40% 
FoR code: 0605, Microbiology, 40% 
FoR code: 0608, Zoology, 20% 
 
 
 
 
! !
 
Table of contents 
1. Chapter I. General Introduction ................................................................................. 1 
1.1 Host defences to infection of the brain and central nervous system ........................ 1 
1.1.1 Blood brain barrier and its role in innate immunity .............................................. 2 
1.1.2 Complement pathways – innate immune system ............................................... 3 
1.2 Streptococcus iniae virulence factors and the onset of meningitis ........................... 7 
1.2.1 Streptococcus iniae Pathophysiology ................................................................. 8 
1.2.2 Streptococcus iniae Virulence factors ................................................................. 9 
1.2.3 Streptococcus iniae Pathogenesis leading to Meningitis .................................... 9 
1.2.4 Putative complement proteases in Streptococcus iniae .................................... 11 
1.3 The effect of growth phase on gene expression .................................................... 17 
1.4 Aims and Hypothesis .............................................................................................. 18 
2. Chapter II. Coordinate inverse regulation of putative complement-degrading 
proteases scpi and cppa with capsule in fish pathogenic Streptococcus iniae ....... 20 
2.1 Introduction ............................................................................................................. 20 
2.2 Materials & methods ............................................................................................... 22 
2.2.1 Bacterial strains and culture conditions ............................................................ 22 
2.2.2 Target gene identification ................................................................................. 22 
2.2.3 Determination of gene expression with respect to growth ................................ 23 
2.2.4 Determination of plastic adherence with respect to growth phase ................... 24 
2.2.5 Whole blood and serum bactericidal assays .................................................... 25 
2.2.6 Data analysis .................................................................................................... 26 
2.3 Results ................................................................................................................... 26 
2.3.1 ScpI and cppA are highly a conserved peptidase and metalloprotease 
respectively ................................................................................................................. 26 
2.3.2 ScpI and cppA are coordinately but inversely regulated with cspE through the 
growth phases ............................................................................................................. 29 
2.3.3 Cell adherence is affected by growth phase ..................................................... 30 
2.3.4 S. iniae growth and survival in whole blood and serum is affected by growth 
phase of the inoculum ................................................................................................. 31 
2.4 Discussion .............................................................................................................. 33 
 
 
! !
 
3. Chapter III. Role of complement proteases in fish pathogenic Streptococcus 
iniae ................................................................................................................................... 38 
3.1 Introduction ............................................................................................................. 38 
3.2 Materials and methods ........................................................................................... 39 
3.2.1 Bacterial strains and culturing ........................................................................... 39 
3.2.2 Isogenic knock-out mutants .............................................................................. 39 
3.2.3 β-hemolysis sheep red blood cells .................................................................... 41 
3.2.4 Survival of ΔscpI and ΔcppA in whole barramundi blood ................................. 42 
3.2.5 Susceptibility of ΔscpI and ΔcppA to killing by serum and antiserum ............... 42 
3.2.6 Statistical analysis ............................................................................................ 43 
3.3 Results ................................................................................................................... 43 
3.3.1 Hemolytic activity of knock-out mutants ΔscpI and ΔcppA was lower than wild 
type  .......................................................................................................................... 43 
3.3.2 Knock-out mutants ΔscpI and ΔcppA did not grow in whole blood ................... 44 
3.3.3 Knock-out mutans ΔscpI and ΔcppA are susceptible to host complement ....... 45 
3.4 Dicussion ................................................................................................................ 46 
4. Chapter IV. Effect of iron limitation on the coordinate regulation of complement 
proteases and capsule in Streptococcus iniae ............................................................. 50 
4.1 Introduction ............................................................................................................. 50 
4.2 Materials and methods ........................................................................................... 51 
4.2.1 Bacterial strains and culturing ........................................................................... 51 
4.2.2 Determination of gene expression .................................................................... 51 
4.2.3 Data analysis .................................................................................................... 52 
4.3 Results ................................................................................................................... 53 
4.3.1 Bacterial growth and sampling points ............................................................... 53 
4.3.2 Effect of iron limitation on the coordinate regulation of complement proteases 
and capsule ................................................................................................................. 54 
4.4 Discussion .............................................................................................................. 55 
5. Chapter V. Discussion .............................................................................................. 58 
5.1 Bacterial strategies to counter the host complement system ................................. 58 
5.2 Relationship between growth phase and gene expression .................................... 61 
5.3 The coordinate regulation of complement proteases and capsule ......................... 62 
 
 
! !
 
5.4 The pleiotropic effect of complement proteases ..................................................... 64 
5.5 The effect of iron limitation on complement proteases and capsule expression .... 66 
6. Chapter VI. References ............................................................................................. 69 
 
 
 
! !
 
List of Figures 
Figure 1. The blood-brain barrier (BBB) model. BBB is constructed from multilayers in 
which (a) adjacent microvascular endothelial cells are the main component and (b) 
connected via tight junction (TJ) and adherent junction (AJ). (Cecchelli et al., 2007) .. 2!
Figure 2. The classical, lectin, and alternative complement pathways ................................ 5!
Figure 3. (A) A ribbon drawing of ScpB monomer. Proteases domain is red which contains 
the active site region (circle), protease-associated domain is green, and the remainder 
comprises three Fibronectin domains. (B) The schematic arrangement of ScpB in 
linear form. The colors representing domains are as in (A). The pink regions, which 
are the pro-domain and cell wall anchor, are not present in mature form of ScpB. 
(Brown et al., 2005) ..................................................................................................... 13!
Figure 4. scpI encoding gene of S. iniae SF1 (GenBank ID 16208933). The black regions 
represent for protease part 1, protease-associated, protease part 2, and fibronectin 
domains, respectively. ................................................................................................. 14!
Figure 5. C3-degrading protease CppA, the ribbon model of a proteinase enzyme from the 
TIGR4 strain of Streptococcus pneumonia. (A) Monomeric unit. (B) Asymmetric unit, 
this model consists of four protein chains. (Nocek B. et al, 2008) .............................. 16!
Figure 6. cppA encoding gene of S. pyogenes (GenBank ID NC_004070.1), in which N- 
and C-terminal chains have been identified. ............................................................... 17!
Figure 7. cppA encoding gene of S. iniae (GenBank ID NC_021314.1), in which the active 
regions are mentioned as the GLo_EDI_BRP_like regions. ....................................... 17!
Figure 8. Amino acid sequences showing key features, predicted structure and 
phylogenetic position for scpI (a) and cppA (b). Conserved functional domains are 
highlighted in green; a) Peptidase S8 family domain in Streptococcal C5a peptidases 
and b) Glo_EDI_BRP_like metalloprotease domains. The transmembrane helix in scpI 
is highlighted in dark blue. ^Catalytic triad residues; #putative polypeptide binding site; 
*Putative active site. Phylogenetic relationships were inferred by maximum likelihood 
 
 
! !
 
with the closes matches by BLAST. Bootstrap support values are indicated ............. 28!
Figure 9. Expression (normalized against three reference genes) of scpI, cppA, and cpsE 
at late exponential and stationary phase relative to mid-exponential phase in Todd-
Hewitt Broth. (A)QMA0248, (B) QMA0076 (Mean ± SD, n = 9; *p<0.05; ***p<0.001) 30!
Figure 10. Surface adherence of S. iniae to plastic at different phases of growth. (A) S. 
iniae QMA0248, (B) S. iniae QMA0076. (Mean ± SD, n = 3; **p<0.01; ***p<0.001) ... 31!
Figure 11. Survival of S. iniae QMA0248 (A) and QMA0076 (B) over 60 min in whole 
barramundi blood when a standardised number of cells from different growth phases 
are used as the starting inoculum. The survival percentage of each growth phase was 
estimated based on the number of colony forming units before and after incubation for 
60 min at 28°C (Mean ± SD, n = 3; significant difference indicated by different letters, 
p<0.05). ....................................................................................................................... 32!
Figure 12. Survival of S. iniae QMA0248 in barramundi serum using inocula from different 
growth phases. HINS: heat-inactivated normal serum, HIAS: heat-inactivated anti-
QMA0248 antiserum, HINS+FS and HIAS+FS: heat-inactivated normal serum or 
antiserum with fresh serum added as a uniform source of complement and other heat-
labile plasma proteins (Mean ± SD, n = 3; *p<0.05; **p<0.01; ***p<0.001) ................ 33!
Figure 13. Isogenic mutagenesis knock out mutants diagram of (A) scpI and (B) cppA in S. 
iniae. Spectinomycin encoding gene aad9 was introduced into the wild type genome of 
S. iniae by allelic exchange mutagenesis between the homologous up- and down-
stream flanking regions. (Locke et al., 2008). ............................................................. 40!
Figure 14. Haemolytic activity of QMA0248 wild type, ΔscpI and ΔcppA against sheep red 
blood cells. Positive control (n=3) was completely lysed by adding Triton X-100. (Mean 
± SD, n = 10; *p<0.06) ................................................................................................. 44!
Figure 15. Survival of QMA0248 wild type, ΔscpI and ΔcppA, at different growth phases in 
barramundi whole blood. (Mean ± SD, n = 3; **p<0.01; ****p<0.001) ......................... 45!
Figure 16. Growth or survival of QMA0248 wild type, ΔscpI and ΔcppA inoculated at 
different growth phases into (A) normal serum, (B) anti-QMA0248 serum, (C) normal 
 
 
! !
 
serum with fresh serum added, and (D) anti-QMA0248 antiserum with fresh serum 
added. (Mean ± SD, n = 3; * p<0.05; **p<0.01; ***p<0.005; ****p<0.001) .................. 46!
Figure 17. Growth of S. iniae strains (A) QMA0076 and (B) QMA0248 grown under Fe-
normal and Fe-limited conditions ................................................................................ 53!
Figure 18. Expression (normalized against three reference genes) of scpI, cppA, and cpsE 
at three growth phases under Fe-limited condition relative to Fe-normal condition. (A) 
S. iniae QMA0076, (B) S. iniae QMA0248 (Mean ± SD, n = 9) ................................... 55!
Figure 19. Growth of S. iniae QMA0248 and S. iniae QMA0076 in Todd-Hewit Broth ...... 94!
 
List of Tables 
Table 1. The sampling time points corresponding to three growth phases under Fe –
normal and –limited conditions .................................................................................... 54!
Table 2. Sampling time points of S.iniae strains grown in Todd-Hewit Broth .................... 94!
Table 3. Primer sequences for fusion PCR to generate knock-out insertion ..................... 94!
 
List of Abbreviations 
aa amino acid 
ANOVA Analysis of Variance 
BBB Blood brain barrier 
BLAST Basic Local Alignment Search Tool 
CFS Cerebral spinal fluid 
CNS Central Nervous System 
CPS Capsular polysaccharide 
DMSO Dimethyl sulfoxide 
dNTP Deoxynucleotide triphosphate 
EDTA Ethylenediaminetetraacetic acid 
 
 
! !
 
ELISA Enzym-linked Immunosorbent Assay 
FS Fresh Serum 
GAS Group A Streptococci 
GBS Group B Streptococci 
HIAS Heat Inactivated Anti Serum 
HINS Heat Inactivated Normal Serum 
IL Interleukin 
IM Intramuscular 
IP Intraperitoneal 
KO Knock Out 
MAC Membrane attack complex 
NCBI National Center for Biotechnology Information 
OD Optical Density 
ORF Open Reading Frame 
PCR Polymerase Chain Reaction 
RBC Red Blood Cell 
RPMI Roswell Park Memorial Institute 
RT Room Temperature 
SDS Sodium sodecyl sulfate 
THA Todd-Hewitt Agar 
THB Todd-Hewitt Broth 
TNF Tumor Necrosis Factor 
WT Wild Type 
 
 
 
 
  General Introduction 
 
! [1]!
 
1. Chapter I. General Introduction 
Streptococcus species, particularly Streptococcus iniae are emerging as the most 
significant pathogens of warm water aquaculture fish species and cause serious economic 
loss to the industry worldwide (for review see Agnew and Barnes, 2007). It is also 
occasionally zoonotic, and is the most common cause of meningitis in neonates (for review 
see Baiano and Barnes, 2009). The disease symptoms presented in streptococcus 
infected mammals and aquatic species are very similar, namely septicemia and meningitis, 
in spite a reductive evolution of marine strains of Streptococci leading to extensive gene 
loss (Rosinski-Chupin et al., 2013). This provides an opportunity to explore conserved 
virulence factors amongst marine and terrestrial strains.  C3 and C5a are two pivotal 
anaphylatoxins of the complement pathway activating a pro-inflammatory response of the 
innate immune system in both humans, and marine fish. Recent studies have indicated a 
pivotal role for these anaphylotoxins in the onset and development of meningitis (Gasque 
et al., 1998; Van Beek et al., 2000). Interestingly, the corruption of the complement system 
by the interference from a C5a peptidase and a C3-degrading protease has been 
demonstrated in Streptococci of group A, B, G in their pathogenesis in mammals (Cleary 
et al., 2004; Hostetter et al., 2004; Ji et al., 1996). Genes encoding these proteins are 
retained in fish pathogenic streptococci, including Streptococcus iniae (Baiano and 
Barnes, 2009; Locke et al., 2008; Zhang et al., 2014). Could manipulation of the 
complement system play a role in the meningeal pathology that results from these 
infections? I aim to understand how marine streptococcal pathogens manipulate the 
complement system and subsequently determine whether there is a role for complement 
manipulation in the development of meningitis during fish infection. This research will help 
to identify key pathways in pathogenesis and identify putative surface targets for future fish 
vaccines for aquaculture. 
1.1 Host defences to infection of the brain and central nervous system 
Meningitis is a serious condition that is characteristic of streptococcal infections in fish, in 
the case of S. iniae, and in humans. It is the inflammation of the meninges, which protect 
the brain and spinal cord. The cerebrospinal fluid contained in the meninges is a source of 
bacteria that may infect and cause the inflammation. In order to understand how S. iniae 
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approaches, invades and causes meningitis in fish, an appreciation of how the host’s 
central nervous system defends itself against pathogens is required, including the concept 
of the blood-brain barrier and how it interacts with the innate immune system. Moreover 
current understanding of strategies for adherence and invasion by streptococcal 
pathogens will be examined.  
1.1.1 Blood brain barrier and its role in innate immunity 
 
Figure 1. The blood-brain barrier (BBB) model. BBB is constructed from multilayers in 
which (a) adjacent microvascular endothelial cells are the main component and (b) 
connected via tight junction (TJ) and adherent junction (AJ). (photo by Cecchelli et al., 
2007) 
The blood-brain barrier (BBB) is constructed from multilayers in which adjacent 
microvascular endothelial cells are the main component (Brightman, 1977) (Figure 1). 
These endothelial cells are connected by adherent junctions and tight junctions at their 
intercellular contacts (Schulze and Firth, 1993; Wolburg and Lippoldt, 2002). Based on 
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these interactions between junctions, the endothelial cells maintain their functions of cell 
polarity, signaling, cell stabilization and thereby BBB integrity (Braga, 2002; Matter and 
Balda, 2003; Wheelock and Johnson, 2003) which is vital to preventing the invasion of 
pathogens. Adjacent to endothelial cells are pericytes (Johanson, 1980). These endothelial 
cells and pericytes are surrounded by a basement membrane (Johanson, 1980) which is in 
turn surrounded by the foot of the astrocyte and neuron endings (Cohen et al., 1995; 
Johanson, 1980; Paspalas and Papadopoulos, 1996). The communications between 
endothelial cells, astrocytes, pericytes are unique cell-cell interactions because of the very 
short distance between these cells (only 20 nm) (Pardridge, 2003; Paulson and Newman, 
1987). 
The BBB has sparse pinocytic activity which restricts large molecules and pathogens from 
entering cells and limits the amount of transcellular flux. It is the last barrier to bacteria 
attempting to enter the homeostatic environment of the Central Nervous System (CNS). 
The multiplication of pathogens within the subarachnoid space is rapid in the absence of 
inhibition by large molecules of the host immune system such as complement and 
immunoglobulins (Ransohoff et al., 2003). Due to this deficiency in host humoral defense 
response within the CNS, migration of leukocytes through BBB compensates for this 
weakness. Indeed, various cells within the BBB and CNS produce the pro-inflammatory 
cytokines tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6) 
(Tauber and Moser, 1999; van Furth et al., 1996) involved in leukocyte recruitment and 
activation. In summary, the BBB plays a role in the immune alert system prior to invasion 
of the CNS, but over-activation may occur with continuous insult from a pathogen leading 
to a loss of BBB integrity (van Sorge and Doran, 2012).  
1.1.2 Complement pathways – innate immune system 
1.1.2.1 Complement pathways 
The complement system is an ancient innate immune pathway that has existed for over 
350 million years and has been found in organisms as primitive as the horseshoe crab 
(Carcinoscorpius rotundicauda) (Zhu et al., 2005) and scleractinian corals (Kvennefors et 
al., 2010). Although the complement system is not adaptable and does not change over 
the lifespan of the host, it can be recruited by the adaptive immune system (Janeway, 
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2001). Employing over thirty plasma proteins, the complement system is a very complex 
network consisting of a cascade of proteolytic events providing immunity against a wide 
variety of pathogens. The major functions of the complement system are opsonizing 
invaders for immune and inflammatory cells, stimulating the immune system and finally 
contributing to the destruction of pathogens as the membrane attack complexes (MAC) are 
formed at the cell surface (Ha nsch et al., 1998; Liszewski et al., 1996). In addition, the 
complement system plays an important role in regulation of humoral immunity (Molina et 
al., 1996), modification of T cells (Kaya et al., 2001), control of the development of 
antibody repertoire (Fleming et al., 2002), and regulation of self-reactive B lymphocytes 
that produce anti-nuclear and anti-dsDNA antibodies (Carroll, 2000; Prodeus et al., 1998). 
It is activated via three pathways, classical, lectin, and alternative pathway (Figure 2). 
The classical pathway is activated by the response of the C1 complex to the interaction of 
IgM or IgG1 and IgG3 with antigen in humans (Mak and Saunders, 2007). The lectin 
pathway is activated by mannose-binding lectins (MBL) (Reid and Turner, 1994), Ficolins 
(Matsushita et al., 2000), and cytokeratin, is present on ischemic endothelial cells (Collard 
et al., 1998) which can recognize the sugar residues anchoring on the pathogen surface. 
The alternative pathway does not require the specific interaction of protein-protein or 
protein-sugar for activation. It has a wide range of activators including bacterial 
polysaccharides and lipopolysaccharides, viral infected cells, yeast cell walls, IgA 
containing immune complexes, inulin, cobra venom factor, and especially, transformation 
of C3 into C3(H2O), subsequently C3b (Yancey and Lazarova, 2008).  
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Figure 2. The classical, lectin, and alternative complement pathways 
 
These pathways are differentiated at the initiation and follow three distinct reaction 
cascades, but they share most components and generate the same variants of the 
protease C3-convertase and C5-convertase (Ha nsch et al., 1998; Huber-Lang et al., 
2006). All three pathways share similar downstream formation of membrane attack 
complexes (MAC). The MAC is a transmembrane channel that can disrupt the 
phospholipid bilayer of the pathogen cell surface leading to the cell lysis and death. 
Whether cleaved by classical, lectin or alternative C5-convertase, C5 is fragmented 
identically resulting in two molecules C5a and C5b. After interacting with C6 to form the 
C5b6 complex, other terminal complement components (i.e. C7, C8) are attracted resulting 
in the formation of complement complexes that are capable of attaching and associating 
deep within the lipid bilayer and thereby disrupting the plasma membrane (Lachmann and 
Thompson, 1970; Thompson and Lachmann, 1970). Finally, C9, which is amphiphilic and 
capable of polymerization, binds to C5b678 to form a transmembrane tubular complex 
poly-C9 (Podack and Tschopp, 1982) that eventually lyses the target cell.  
1.1.2.2 Complement system in fish 
The complement system in aquatic animals has similar properties to their mammalian 
counterparts (Boshra et al., 2006; Holland and Lambris, 2002). Cytolysis and opsonisation 
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for later phagocytosis by the fish complement system have been confirmed in a range of 
fish species (Byon et al., 2006; Gonzalez et al., 2007; Jenkins and Ourth, 1993; Lammens 
et al., 2000; Matsuyama et al., 1992; Moritomo et al., 1988; Overturf and LaPatra, 2006; 
Saeij et al., 2006; Sakai, 1984; Sigh et al., 2004). The fry of trout and masu salmon, which 
do not possess complement activity at this stage of development, are more susceptible to 
infectious haematopoietic necrosis virus infectious pancreatic necrosis virus than their 
Atlantic salmon fry counterpart which already possess complement activity in serum 
(Yano, 1997). In rainbow trout, the complement components present in the skin and serum 
can kill the parasites Gyrodactylus derjavini, Gyrodactylus salaris, Ichthyophthirius 
multifiliis, Cyptobia salmositica through both classical and alternative complement 
pathways (Buchmann, 1998; Buchmann et al., 2001; Harris et al., 1998; Woo, 1996). 
Interestingly, the fish complement proteins, which are structurally similar to those of 
mammals, appear to possess many isoforms (e.g. C3 and factor B) which may be 
transcribed from more than one gene (Holland and Lambris, 2002). Indeed, the genes 
coding for C3 in fish are polymorphic and may lead to multiple mechanisms of activation 
(Jensen and Koch, 1991; Nonaka et al., 1985).  
C3- and C5-convertase are universal complexes formed by three pathways, and they are 
essential for the formation of key components C3a and C5a thus are essential to 
progression of the lytic complement pathway, initiation of the pro-inflammatory response 
and activation of migrating leukocytes. 
1.1.2.3 C3a and C5a Anaphylatoxins  
The proteolytic reactions of C3, C4, and C5 result in lower molecular-weight fragments 
C3a, C4a, and C5a that are anaphylatoxins based on their pro-inflammatory action, 
promoting the release of vasoactive mediators from mast cells and basophils (Gorski et al., 
1979; Yancey, 1988). They share a sequence homology of up to ≈35%, a carboxy-terminal 
arginine and the relative order of activity strength descends from C5a to C3a, then C4a 
(Barnum et al., 2002; Dahinden et al., 1991; Elsner et al., 1994; Hartmann et al., 1997; 
Norgauer et al., 1993; Settmacher et al., 1999; Van Epps et al., 1993). 
C5a weighs 12-14.5 kDa and is composed of 74-amino acids, in which Asn64 has N-linked 
carbohydrate that is likely control the activity of C5a in vivo (Monk et al., 2007). In terms of 
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activity, C5a is 200 times more potent than C3a (Yancey and Lazarova, 2008) and its 
effects are pleiotropic including induction of smooth muscle contraction (Gasque et al., 
1998; Haviland et al., 1995; Zwirner et al., 1999), stimulation of histamine from mast cells, 
chemoattraction of neutrophils, monocytes, macrophages (Becker, 1972; Snyderman et 
al., 1970; Snyderman et al., 1975), eosinophils (Kay et al., 1973), basophils (Hook et al., 
1975), liver Kuppfer cells (Laskin and Pilaro, 1986), microglia in the CNS (Yao et al., 
1990), and also B and T lymphocytes (El-Naggar et al., 1980). In addition, C5a also 
participates in activating oxidative burst in neutrophils, and promotes phagocytosis 
(Goldstein and Weissmann, 1974; Guo and Ward, 2005; Marder et al., 1985; Sacks et al., 
1978). The over-expression of C5a is found in inflammatory disorders implying under-
regulation in these diseases (Monk et al., 2007). 
C3 is a 185 kDa protein and is the dominant complement protein in terms of relative 
quantity (Haas and van Strijp, 2007). C3 consists of two chains, α- and β-chain, which are 
cleaved at the site between Arginine-77 and Serine-78 on the α-chain by C3-convertase of 
any of the classical, lectin, or alternative pathways, resulting in fragments C3a and C3b 
(Beutler, 2004). C3b continuously combines with other complement components to form 
the proteolytic complexes. C3a, which is a 77-amino acid fragment, is a pro-inflammatory 
mediator participating in cellular and physiological events including contraction of smooth 
muscle, activation of leukocytes, eosinophils, and promotion of vascular permeability 
(Gerard and Gerard, 2002; Hawlisch et al., 2004). C3a causes a broad-ranging pro-
inflammatory effect and C3a receptors are found on activated lymphocytes and endothelial 
cells during the inflammation of the brain (Fischer and Hugli, 1997; Francis et al., 2003; 
Gasque et al., 1998; Monsinjon et al., 2001). 
In summary, the two anaphylatoxins C3a and C5a are the most potent pro-inflammatory 
mediators and are integral to all three of the complement pathways thus constituting 
efficient evolutionary targets for interference by proteases of pathogenic bacteria. 
1.2 Streptococcus iniae virulence factors and the onset of meningitis 
When Streptococcus iniae invades the host and enters the bloodstream it uses the 
polysaccharide capsule as a shield against the host defense system, particularly 
phagocytosis and complement (Doran et al., 2003; Kim et al., 1992; Nizet et al., 1997; St 
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Geme and Falkow, 1991; Unkmeir et al., 2002). However, meningeal pathogens depress 
capsular expression prior to adhesion to host cells that may be required during attack on 
the CNS (Hammerschmidt et al., 1996; Ring et al., 1998; St Geme and Cutter, 1996; St 
Geme and Falkow, 1991). The reduction in host-cell adhesion when capsule is expressed 
is a result of decreased exposure of critical surface proteins and/or through electrostatic 
repulsion leading to failure of binding to host cells (Hammerschmidt et al., 1996; Ring et 
al., 1998). However, in the case of insufficient capsular cover, the pathogen is at high risk 
of clearance by the host’s innate immune system, particularly the complement system, 
unless it initiates another protecting system.  
Some bacterial pathogens have evolved mechanisms to resist host complement that 
include avoiding, exploiting or disrupting the complement system (Kuo et al., 2008; Terao 
et al., 2008; Tsao et al., 2006). Invaders may (i) utilize host complement regulators (e.g. 
factor H and factor H-like protein (Zipfel et al., 2002)), (ii) employ bacterial complement 
inhibitors (e.g. CD59-like protein from Borrelia burgdorferi (Pausa et al., 2003)),and  (iii) 
degrade complement components by bacterial proteases (Rooijakkers and van Strijp, 
2007). The degradation and/or modulation of the functional activity of complement proteins 
by bacterial proteases are considered essential and almost exclusive invasion strategy of 
many bacterial pathogens. It involves directly degrading the substrates or incorporating 
them with host proteases to attenuate them (Michal and Jan, 2012).   
Bacterial proteases are employed by mammalian pathogens however it is unknown 
whether marine counterparts employ the same systems. The disease symptoms caused 
by Streptococcal species are quite similar despite evolutionary gene loss which presents 
an opportunity to explore conserved virulence factors amongst the reduced genomes and 
their human and mammalian counterparts. 
1.2.1 Streptococcus iniae Pathophysiology 
The clinical symptoms of S. iniae can vary between host species. In humans, symptoms 
include bacteraemic cellulitis in organs or joints, endocarditis, meningitis, osteomyelitis, 
and septic arthritis (Facklam et al., 2005; Lau et al., 2003; Weinstein et al., 1997). In 
dolphins multifocal subcutaneous abscesses are the only recorded symptom to date 
(Bonar and Wagner, 2003; Pier and Madin, 1976; Pier et al., 1978). In tilapia (Oreochromis 
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aura, Oreochromis nilotica), trout (Oncorhynchus mykiss), common carp (Cyprinus 
carpus), grey mullet (Mugus cephalus), yellowtail (Seriola quinqueradiata), Coho salmon 
(Oncorhynchus kisutch) and barramundi (Lates calcarifer), clinical signs are the loss of 
orientation, melanosis, tachypnea, anorexia, emaciation, corneal opacity, mild peritonitis, 
lethargy, petechiae around the anal zone, gill rot, dorsal rigidity, vertebral deformity, 
scattered haemorrhages in the body cavity, osteomyelitis and sudden death have also 
been reported in acutely infected fish (Eldar et al., 1994; Eldar et al., 1995; Eldar and 
Ghittino, 1999; Eldar et al., 1997; Kaige et al., 1984).  
1.2.2 Streptococcus iniae Virulence factors 
Virulence factors that present on the pathogen surface or are secreted are critical in the 
promotion of adhesion, invasion, and resistance to the host immune system. They are also 
potential targets for vaccination due to their exposure to the adaptive immune system 
during infection. In S. iniae, the predominant virulence factor is its capsule, which has been 
found in almost all virulent isolates, and confers resistance to phagocytosis by fish 
macrophages (Locke et al., 2007). This capsular polysaccharide can cover surface 
antigens, prevent opsonisation by complement C3 and macrophage clearance (Barnes et 
al., 2003; Buchanan et al., 2005; Miller and Neely, 2005).  
The secreted enzymes playing roles in S. iniae pathogenesis consists of IL-8 protease, 
C5a peptidase, streptokinase, and superantigens (Nobbs et al., 2009). IL-8 protease is 
responsible for cleavage IL-8 produced as a pro-inflammatory cytokine by the host innate 
defense system, resulting in increased bacteria survival and proliferation (Zinkernagel et 
al., 2008). Interfering with host complement pathway, C5a peptidase is postulated to 
hydrolyse the strong anaphylatoxin C5a (Locke et al., 2008; Tamura et al., 2004). In S. 
iniae, C5a peptidase is 123 kDa, has similar structural features to those of Group A 
Streptococci (GAS), and possesses classical Gram-positive anchor motif LPXTG (Locke et 
al., 2008). However, the contribution of this protein to S. iniae virulence is uncertain as 
allelic exchange of its encoding gene, scpI did not result in substantial attenuation of 
virulence in fish (Locke et al., 2008).  
1.2.3 Streptococcus iniae Pathogenesis leading to Meningitis 
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The general bacterial pathogenesis leading to meningitis is a multistep infection process 
including the colonization followed by entering the CNS; then bacterial replication occurs in 
the subarachnoid space and ventricular system. This leads to a host inflammatory 
response which results in damage of the neural system (Leib and Täuber, 1999). 
1.2.3.1 Entry of infection and colonization  
Route of infection by S. iniae was explored by Evans et al. (2000) in hybrid striped bass 
(Morone chrysops x Morone saxatilis) and tilapia (Oreochromis niloticus) (Evans et al., 
2000), suggesting common route of infection via nares. Barramundi (Lates calcarifer) can 
be infected with S. iniae via many routes including oral, bath exposure, intra-peritoneal 
injection, olfactory route, contact with or cannibalization of infected fish (Bromage and 
Owens, 2002; Shoemaker et al., 2000). In 2003, Zlotkin et al. suggested that the 
pathogenesis of S. iniae may be initiated by colonization of external or gastrointestinal 
tissues, from which it starts spreading by entering the blood stream (Zlotkin et al., 2003). 
Once the meningitis pathogens translocate to the sub-epithelial blood vessels, their 
colonization is enhanced depending on the surface components of that pathogen including 
fimbriae, capsule, and exonuclease (Leib and Täuber, 1999).  
1.2.3.2 Survival within bloodstream 
Once inside the blood vessels and intra- or inter-cellular space, pathogens must battle 
against the hosts defense mechanisms (antibodies, complement pathways and 
phagocytosis) (de Vries et al., 1996). The first defense that pathogens must face is the 
non-specific alternative and lectin complement pathways of the host. Once complement is 
activated, complement C3 is cleaved resulting in the binding of C3b on bacterial surface 
followed by a cascade of complement component cleavage and binding as well as 
opsonisation (enhancing ‘visibility’) for phagocytosis. Capsular polysaccharide is critical for 
avoiding phagocytosis and for resistance to complement mediated lysis during this phase 
of rapid expansion (Eyngor et al., 2010; Lowe et al., 2007; Martins et al., 2010).  
1.2.3.3 Breaching Blood Brain Barrier and penetration of the Cerebral Spinal Fluid 
The movement of blood-borne pathogens through the BBB starts with their attachment to 
the brain microvascular endothelial cells. Meningeal pathogens are aided by receptors 
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located within the endothelium of the choroid plexus and cerebral capillaries as well as by 
low blood flow in the choroid plexus (Mairey et al., 2006). From this state, the pathogen 
can penetrate (i.e. transcellularly) the endothelial cell (Das et al., 2001; Greiffenberg et al., 
1998; Jain et al., 2006; Nikulin et al., 2006; Nizet et al., 1997; Prasadarao et al., 1999; 
Ring et al., 1998; Stins et al., 2001; van Sorge et al., 2011) or move aside (i.e. 
paracellularly) the endothelial cells via junction route (van Sorge and Doran, 2012) to enter 
the cerebral spinal fluid (CSF) compartment. Once the pathogens enter the endothelial 
cells, inflammation will be stimulated by cytokine activation which increases the amount of 
receptors capable of binding with phosphorylcholine; this creates an advantage for some 
bacterial pathogens to further their invasion (Banerjee et al., 2010; Cundell et al., 1995; 
Ring et al., 1998; Zhang et al., 2002).  
The successful adherence and invasion of meningeal pathogens with ineffective capsules 
(Doran et al., 2003; Nizet et al., 1997; Unkmeir et al., 2002) shows that pathogens have an 
alternative strategy which enables them to remain virulent and protect them from host 
phagocytosis, but also that capsule is not required, or may even be an impediment to host 
cell adhesion. This means, at least in terms of capsular polysaccharide, there is a trade-off 
between resistance to innate immune defences and the adhesion that must occur in order 
to initiate crossing of the BBB. 
1.2.4 Putative complement proteases in Streptococcus iniae 
1.2.4.1 C5a peptidase 
C5a peptidase Scp (Streptococcal C5a peptidase) is a branch of the subtilisin family of 
serine proteases, which can cleave C5a near its N-terminus, i.e. between His-67 and Lys-
68 within the binding site for polymorphonuclear leukocytes, resulting in the recognition 
region of C5a with its receptor is removed (Wexler et al., 1985). The disruption of C5a 
results in the slowdown of influx of polymorphonuclear neutrophil leukocytes through 
failure of chemotactic signaling and neutrophil attraction to the infection site (Cleary et al., 
1992). Interestingly, unlike other serine proteases, Scp only acts on C5a, not C5 or other 
proteins (Ji et al., 1996). Based on the cleavage of C5a at an inaccessible site His-Lys, 
and the observation that C5 is resistant to Scp, it strongly indicates that Scp is highly 
specific for C5a (Cleary et al., 1992). 
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Group A, B, C, G Streptococci, the β-hemolytic species, express a cell wall-anchored 
protein C5a peptidase Scp (Hill et al., 1988). Both Group A and B Streptococci possess 
the mechanism to escape from phagocytosis. The clearance of GAS at the infection site is 
delayed when Scp is expressed on its surface (Hung et al., 2012). Additionally, ScpB acts 
as an adhesin to Fibronectin type III and enhances invasion of epithelial cells (Beckmann 
et al., 2002).  Interestingly, anti-ScpB antibody opsonizes Group B Streptococci (GBS) 
across serotypes, resulting in increased killing rate and macrophage oxidative burst 
(Cheng et al., 2001). It is possible that a novel vaccine for GBS will be made from ScpB, 
and similarly with ScpA in GAS. Scp is highly conserved among species, and the similarity 
of Scp proteins produced in GAS and GBS is up to 98% (Chmouryguina et al., 1997; 
Chmouryguina et al., 1996). For consistency, Scp is generally known as ScpA in GAS, 
ScpB in GBS, and ScpI in S. iniae, which is not type-able by the Lancefield system. 
In GAS, ScpA consists of 1167 amino residues and is 128,814 Da. The signal sequence 
comprises the first 31 amino acid, including hydrophilic residues as a basement, 
hydrophobic as a core, and a cleavage site (Chen and Cleary, 1990; von Heijne, 1983). 
The next 68 amino acids, the propeptide, are also removed in the process of maturation of 
the Scp protein (Anderson et al., 2002). The highly conserved active site of ScpA is formed 
by Asp130, His193 and Ser512 that locate in the NH2-terminal (Chen and Cleary, 1990; 
Siezen et al., 1991). In GBS, ScpB is also translated in the same manner as GAS 
(Chmouryguina et al., 1996) in that cleavage occurs between Ala31 and Arg32. Also, the 
active site triad Asp130, His193 and Ser509 is conserved (Chen and Cleary, 1990; Siezen 
et al., 1991). Located next to the carboxy terminus is a region of glycine and proline, which 
is an anchor-region for the peptidoglycan cell wall (Fischetti, 1989). This cell wall 
attachment domain is deduced as 20-residue hydrophilic sequence, a hydrophobic core of 
17 residues which stretch from the glutamic acid residue at position 1029, and a COOH-
terminus (Chen and Cleary, 1990; Janulczyk and Rasmussen, 2001; Schneewind et al., 
1995; Uhlen et al., 1984) (Figure 3). 
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Figure 3. (A) A ribbon drawing of ScpB monomer. Proteases domain is red which contains 
the active site region (circle), protease-associated domain is green, and the remainder 
comprises three Fibronectin domains. (B) The schematic arrangement of ScpB in linear 
form. The colors representing domains are as in (A). The pink regions, which are the pro-
domain and cell wall anchor, are not present in mature form of ScpB. (Brown et al., 2005) 
 
The C5a protease-like protein ScpI in S. iniae also possesses the serine protease triad 
active sites Asp130, His193, and Ser512, however these amino acids are distributed in a 
slightly different manner to Asp114, His181 and Ser501 (Locke et al., 2008). This may 
suggest that the proteolysis function of this Scp-like protease plays a minor role in the 
virulence of S. iniae (Locke et al., 2008).  
In 2008, Locke et al. identified a candidate Scp-like gene in S. iniae strain K288 named 
ScpI with sequence similar (37% identity and 55% positive (Locke et al., 2008)) to GAS 
Manfredo M5 strain (Holden et al., 2007) and GBS S. agalactiae strain A909 (Tettelin et 
al., 2005). scpI is a gene of 3369 bp at position 952620-955988 distally from simA, which 
encodes for M-like protein (Locke et al., 2008). The position in S. iniae is more similar to 
that of Group C and G Streptococcus rather than to GAS (Geyer and Schmidt, 2000).  
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Upstream of ScpI is a sugar ABC transporter gene satA which is 957 bp and identical to 
that of GAS (Ferretti et al., 2001). Adjacent downstream of scpI is 237 bp, a divergently 
transcribed transposase tnpA (Locke et al., 2008). Proximally located, upstream of tnpA, is 
498 bp phosphoglucomutase gene pgmA which is involved in polysaccharide expression 
in S. iniae and contributes to virulence in fish (Buchanan et al., 2005). In the latest 
published S. iniae genome on GenBank in October 2013 (gene ID 16208933), the scpI of 
S. iniae strain F1 has slightly different neighbouring genes. Starting from the left, the first is 
a gene encoding for ABC transporter-ATP-binding protein, next is a branched-chain amino 
acid ABC transporter-permease protein encoding gene, followed by a satA gene, the scpI 
gene and finally two divergently transcribed genes of PgmA and membrane protein. 
The ScpI-like protein likely possesses conserved domains with GAS and GBS, consisting 
of two peptidase regions flanking the protease-associated domain, and Fibronectin III 
domains (Figure 4). 
 
Figure 4. scpI encoding gene of S. iniae SF1 (GenBank ID 16208933). The black regions 
represent for protease part 1, protease-associated, protease part 2, and fibronectin 
domains, respectively. 
 
1.2.4.2 The putative C3-degrading protease 
The CppA protease is the surface peptidase that was first described in Streptococcus 
pneumoniae being capable of degrading the human complement protein C3 by Hostetter 
et al in 2004 (Hostetter et al., 2004). The molecular weight of this proteases isolated from 
the wild type Streptococcus pneumoniae ranges from about 24 kDa to 34 kDa determined 
by 10% SDS-PAGE (Hostetter et al., 2004) and the protein residue of cppA protein among 
Streptococci is variable e.g. 241 amino acid (aa) in S. pneumoniae (WP_001102220.1) 
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(Tettelin et al., 2001), 250 aa in S. dysgalactiae subsp. equisimilis (YP_002997602.1) 
(Shimomura et al., 2011), 250 aa in S. pyogenes (NP_269848.1)(Ferretti et al., 2001), 251 
aa in S. agalactiae (WP_000171842.1) (Tettelin et al., 2005),  255 aa in S.salivarius 
(WP_014632660.1) (Guedon et al., 2011). Human C3 complement protein is completely 
preferentially degraded β-chain than α-chain that without produced the defined fragments, 
which can be observed on SDS-PAGE (Angel et al., 1994); however the CppA isolated 
from S.pneumoniae preferentially cleave the α-chain than the β-chain (Hostetter et al., 
2004). This protease is highly conserved among the Streptococcus equinus, 
Streptococcus bovis and considered as a virulence factor together with others i.e. 
adhesion factors, immunoreactive antigens, superantigens, toxins, DNases as well as an 
factor involving in the capsule expression regulation (Kadioglu et al., 2002; Papadimitriou 
et al., 2014b). In 1994, the C3-degrading activity was demonstrated on the capsulated and 
uncapsulated S. pneumoniae that the degradation occurred independently with the 
capsule expression (Angel et al., 1994). This previous study also demonstrated the 
degrading activity of substantial proportion of soluble C3 occurred within 30 min in the 
exponential growth phase, and this degradation occurred before the opsonizing because 
the cleaved fragment generated by proteolytic degradation of opsonized C3b was not 
obtained (Angel et al., 1994). In Streptococcus pneumoniae, isogenic C3-degrading 
protease mutants cause less mortality and tissue damage than the wild type (Hostetter et 
al., 2004). In terms of complement pathway corruption, CppA can cleave the C3 
component and prevent the formation of the C5 convertase complex. The cleavage of C3 
leads to failure of opsonizing bacteria by C3b, which prevents the formation of extreme 
pro-inflammatory mediator C5a, the assembly of MAC and ultimately phagocytosis by 
neutrophils. In GBS, the decrease of virulence in the invasion was demonstrated that 
being related to the decrease of C5a peptidase and C3-degrading protease (Sharma et al., 
2013). 
In the genomic sequence analysis of S. iniae, Locke et. al. (2008) suggested that a 
putative C3 protease encoding gene may inactivate the process upstream of C5a 
peptidase (Locke et al., 2008). The putative C3-degrading protease was published in the 
complete genome sequence of S. iniae SF1 isolated from fish by Zhang et al (GenBank ID 
AGM99589.1) (Zhang et al., 2014). However in the two later complete sequences of 
S.iniae from Tilapia i.e. strain ISNO and ISET0901, this protein was listed as peptidase 
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(AHY18370.1 and AHY16506.1) (Pridgeon et al., 2014a, b) although it has 99-100% 
identity to C3-degrading protease of Zhang et al., (2014) by BLAST, which warrants further 
investigation. The protease coding gene cppA was also found in other Streptococci such 
as S. dysgalactiae subsp. equisimilis that is closely related to S. iniae (Shimomura et al., 
2011). Among the virulence factors that may enhance pathogenesis, cppA appears to be 
conserved in Streptococci despite of the various positions of cppA in their genome. In 
addition, the multi-alignment of cppA among S. agalactiae, S. mutants, S. pneumoniae, S. 
pyogenes, and S. sanguinis indicates the number of variable sites is 579 (76.89%) out of 
753 bp aligned.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. C3-degrading protease CppA, the ribbon model of a proteinase enzyme from the 
TIGR4 strain of Streptococcus pneumonia. (A) Monomeric unit. (B) Asymmetric unit, this 
model consists of four protein chains. (Nocek B. et al, 2008) 
The putative C3-degrading protease encoding gene cppA contains four open reading 
frames in which the third ORF is interrupted by the homologous recombination impairing 
the C3 degradation i.e. the translated protein from ORF3 does not share the substantial 
homology to the others (Hostetter et al., 2004). Also, the CppA encoding gene is translated 
into N- and C-terminal chains that are clearly specified in S. pyogenes (Figure 6), however 
in S. iniae those regions are currently noticed as GLo_EDI-BRP_like domains, which 
belong to the superfamily found in the variety of structurally related metalloproteins (Figure 
7). In term of coordinate genes regulation, C3-degrading protease encoding gene has 
been demonstrated that its expression has relation with capsule in Streptococcus bovis 
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and Streptococcus equinus (Papadimitriou et al., 2014a). 
 
 
 
Figure 6. cppA encoding gene of S. pyogenes (GenBank ID NC_004070.1), in which N- 
and C-terminal chains have been identified. 
 
 
 
Figure 7. cppA encoding gene of S. iniae (GenBank ID NC_021314.1), in which the active 
regions are mentioned as the GLo_EDI_BRP_like regions. 
 
1.3 The effect of growth phase on gene expression 
During growth, bacteria themselves change the conditions of their environment as a direct 
consequence of the cost of their increasing density through production of toxic metabolites 
and exhaustion of vital micro and macronutrients, which explains why they have different 
growth phases, i.e. growth rates, during their life cycle in closed culture systems. Recent 
studies have demonstrated that this phase-variable growth rate dependence is directly 
linked to gene expression through a complex regulatory network involving signal cascades 
that adapt to environmental change (Klumpp et al., 2009; Neidhardt et al., 1990; 
Schaechter et al., 1958; Scott and Hwa, 2011). This adaptation to the environment means 
that proteins should be made only when needed. However some genes are expressed 
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constitutively to enable minimum metabolic activity for survival and DNA repair in the 
‘waiting’ mode before and after the environment change (Fischer and Sauer, 2005). 
Expression of genes encoding virulence factor regulatory proteins such as the Mga 
regulon and catabolite control protein CcpA has been shown to be strictly dependent on 
the growth phase i.e. their maximum expression is with the exponential and the plateau 
phase in vitro (McIver and Scott, 1997; Unnikrishnan et al., 1999).  The multifunctional 
protease SpeB (which has C3 degrading activity) is also highly expressed during the 
exponential growth phase and is strongly affected by culture pH and nutrient availability 
(Chaussee et al., 1997; Loughman and Caparon, 2006).  
1.4 Aims and Hypothesis 
Meningeal pathogens cause severe diseases in fish and mammals. Intriguingly, S. iniae 
can cause meningeal symptoms in both humans and fish, yet fish pathogenic Streptococci, 
even of the same species, have greatly reduced genomes compared with their human 
pathogenic counterparts (Rosinski-Chupin et al., 2013), narrowing down the potential 
repertoire of genes that may be critical in causing meningeal infections. There is a trade-
off between innate immune resistance that is required for rapid proliferation in the blood 
and the cellular adhesion that is required to cross the BBB, in that the Capsular 
polysaccharide (CPS) which appears to be critical for survival in the blood plays no role or 
impedes cell adhesion. Thus I hypothesized that (i) S. iniae possessed alternative systems 
to CPS that protect it from innate immunity, namely a complement manipulation system 
which employs C3- and C5a-proteases to corrupt the complement pathway of the host 
innate immune system, (ii) these genes were coordinately regulated with CPS expression 
to protect against complement and phagocytosis whilst permitting cellular adhesion to 
allow the development of meningitis.  
I employed the gene encoding the priming phosphoglycosyl transferase cpsE in the cps 
operon as a proxy for CPS expression and investigated how this was regulated through 
the growth phase in comparison to two complement proteases, cppA and scpI. I 
investigated coordinate regulation of these genes with the capsular polysaccharide using 
real time PCR to explore relative expression levels of scpI and cppA in S. iniae along with 
the initiator critical for CPS expression, cpsE through the growth phases in both iron-
normal and -limited conditions. I also tested the role of these proteins in cell adhesion by 
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investigating ability of S. iniae to adhere to plastic surface at different points of the growth 
phase. Finally, I investigated the roles of these proteases in complement resistance by 
making isogenic knockout mutants in S. iniae and testing complement resistance in in vitro 
assays of whole blood and serum killing.  
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2. Chapter II. Coordinate inverse regulation of putative complement-
degrading proteases scpi and cppa with capsule in fish pathogenic 
streptococcus iniae 
2.1 Introduction 
Streptococcus species, including Streptococcus iniae, are emerging as significant 
pathogens causing meningitis and septicaemia in diverse hosts ranging from fish to 
mammals, including man (Agnew and Barnes, 2007). The disease symptoms presented in 
streptococcus-infected mammals and aquatic species are very similar in spite of reductive 
evolution of marine strains of Streptococci leading to extensive gene loss (Rosinski-Chupin 
et al., 2013). This provides an opportunity to explore conserved virulence factors amongst 
marine and terrestrial strains that may help to elucidate critical pathways in the 
development of disease symptoms  
During infection, bacteria that cause septicemia are exposed to the blood-borne innate 
immune defences of the host including the complement system and phagocytic cells. 
During this phase, in Streptococcus species, the polysaccharide capsule that surrounds 
the bacterial cell is employed to protect them (Doran et al., 2003; Kim et al., 1992; Nizet et 
al., 1997; St Geme and Falkow, 1991; Unkmeir et al., 2002). Indeed, this capsule is found 
in almost all virulent strains of Streptococcus, and in all rapidly virulent septicaemic 
isolates (Locke et al., 2007; Millard et al., 2012). The capsule appears to protect against 
complement either by directly preventing deposition of complement protein C3b on the 
surface, or simply by being physically too thick to allow penetration of the membrane 
attack complex (Barnes and Ellis, 2004), which is the end product of the cascade of 
complement proteins in order to lyse the cell (Ha nsch et al., 1998; Liszewski et al., 
1996). However, capsule deficient isolates of Group B Streptococcus can still enter the 
central nervous system (CNS) (Doran et al., 2005; Martins et al., 2010; Morona et al., 
2006). Moreover, capsule defective variants of S. iniae preferentially invade the spinal 
column of barramundi, but do not cause septicaemia (Millard et al., 2012). This capsule-off 
status places the bacteria at high risk of lethal attack by complement in the blood stream.  
How Streptococcus species translocate into CNS is unknown, but attachment to and 
translocation across the blood brain barrier must be required, with potential disruption to 
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the blood brain barrier (BBB). Intriguingly, capsule has been shown to impede cell 
attachment by other species of streptococcus to cell lines (St Geme and Falkow, 1991). 
Therefore the bacteria may depress capsule expression in order to attach to the 
microvascular endothelium of the BBB (Nobbs et al., 2009; Zinkernagel et al., 2008). 
However, this is also likely to expose the bacteria to lethal risk from the blood-borne innate 
immune defences. Therefore alternate strategies must be employed to resist these 
defences in a capsular deficient situation. 
The innate immune system inside the central nervous system differs from that of the 
circulatory system. In contrast to the blood, the unique environment of the CNS is 
protected by the BBB, composed of microvascular endothelial cells connecting together 
via very tight junctions and adherent junctions (Schulze and Firth, 1993; Wolburg and 
Lippoldt, 2002). The cells are surrounded by pericytes, astrocytes, and the endings of 
neuron cells (Johanson, 1980). This multilayer barrier prevents the access of pathogens 
and large molecules including immune cells from the circulatory system (Ransohoff et al., 
2003). BBB itself can produce complement components for the brain; hence the 
complement system is still active within the CNS and potentially constitutes an important 
immune defence in this protected environment (Tauber and Moser, 1999; van Furth et al., 
1996). Therefore invasive streptococcus species must retain defence against complement 
whilst adhering to and translocating across the BBB. 
C3 and C5a are two pivotal anaphylatoxins of the complement pathway activating a pro-
inflammatory response in both humans and marine fish. Recent studies have indicated a 
pivotal role for these anaphylotoxins in the onset and development of meningitis (Gasque 
et al., 1998; Van Beek et al., 2000). The two anaphylatoxins C3a and C5a are the most 
potent pro-inflammatory mediators and are integral to all three of the complement 
pathways thus constituting efficient evolutionary targets for interference by proteases of 
pathogenic bacteria. Interestingly, the corruption of the complement system by the 
interference from a C5a peptidase and a C3 protease has been demonstrated in 
Streptococci of group A, B, G in their pathogenesis in mammals (Cleary et al., 2004; 
Hostetter et al., 2004; Ji et al., 1996). Genes encoding these C5a peptidase and C3 
protease are retained in fish pathogenic S. iniae named scpI and cppA, respectively 
(Baiano and Barnes, 2009; Locke et al., 2008; Zhang et al., 2014). C5a peptidase Scp 
(Streptococcal C5a peptidase) is a branch of the subtilisin family of serine proteases 
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(Wexler et al., 1985; Wexler and Cleary, 1985), and C3-degrading proteinase belongs to 
cppA family protein (Okumura et al., 2012; Zhang et al., 2014). The disruption of C5a and 
C3 results in the slowdown of influx of polymorphonuclear neutrophil leukocytes through 
failure of chemotactic signalling and neutrophil attraction to the infection site (Beckmann et 
al., 2002; Hostetter et al., 2004; Locke et al., 2008). 
I aim to understand how aquatic streptococcal pathogens manipulate the complement 
system and capsular expression to determine whether there is a role for complement 
manipulation in the development of meningitis during fish infection. This will help to identify 
key pathways in pathogenesis and identify putative surface and secreted targets for future 
fish vaccines for aquaculture. 
2.2 Materials & methods 
2.2.1 Bacterial strains and culture conditions 
Streptococcus iniae strains QMA0248 and QMA0076 (Aviles et al., 2013) were stored in 
Todd-Hewitt broth (THB) containing 20% glycerol at -800C. Isolates were cultured routinely 
on sheep blood agar plate (Oxoid, Australia) at 280C for 12-24h. For broth starter cultures, 
a single colony was used to inoculate Todd-Hewitt broth and incubated at 280C with gentle 
agitation for 12-18 h. For growth curves, 30 µl  aliquots taken from overnight broth cultures 
with optical density (OD) at 600 nm adjusted to 1.0, were used to inoculate 1470 µl  fresh 
THB in 24 well tissue culture plates. Growth was recorded by measuring optical density 
600 nm over time using a Fluostar Optima Microplate Reader (BMG Labtech, Melbourne). 
Mid-exponential, late exponential, and stationary phases were determined from at least 
three replicate experiments with each plate incorporating un-inoculated negative control 
wells. 
2.2.2 Target gene identification 
In order to evaluate relative regulation of capsular expression and complement protease 
expression, genes for C3 protease, C5a peptidase and cpsE (a putative phosphoglycosyl 
transferase in the capsular operon (Lowe et al., 2007) were chosen. The C5a peptidase 
coding genes scpI of S. iniae was retrieved from the sequence of strain SF1 (GenBank 
CP005941.1). The C3-degrading protease coding gene of S. iniae was retrieved by BLAST 
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analysis using cppA from S. dysgalactiae subsp. equisimilis against the whole genome 
sequence of SF1 due to the close phylogenetic relation of these species (Tapp et al., 
2003). The resulting amino acid sequences were then analysed for conserved domains by 
BLAST against the conserved domain database at NCBI (Marchler-Bauer et al., 2015). 
Putative signal peptides and cleavage sites were predicted using Signal P4.1 (Nielsen et 
al., 1999a) and molecular weight and pI estimated using ProtParam (web.expasy.org/cgi-
bin/protparam/). Next, proteins were modelled using Phyre2 and putative proteolytic active 
site and metal binding domains identified (Kelley and Sternberg, 2009). Phylogenetic 
relationships between the proteases and their closest matches by BLAST were inferred by 
maximum likelihood with Mega 5.2 for Macintosh and supported by bootstrap of 1000 
replicates. The putative phosphoglycosyl transferase cpsE was as previously published 
(Lowe et al., 2007). 
For normalization of gene expression, three house-keeping genes including DNA gyrase A 
gyrA (Aviles et al., 2013), glutamine synthetase glnA, and serine dehydratase sdhA were 
also retrieved from whole genome sequences by BLAST. Primers for qRT-PCR specific for 
the three target genes and three reference genes were designed with Primer Express 
3.0.1 (Applied Biosystems). 
2.2.3 Determination of gene expression with respect to growth 
Each strain was cultured in 24-well plates with three biological replicates in THB as 
described above. The sample points were mid-exponential phase, late exponential phase, 
and early stationary phase. At each sample point, 500 µl of sample was taken from each of 
3 replicate wells per strain per treatment for optical density measurement at 600nm, and 
the cells from the remaining 1ml were immediately pelleted at 10,000 x g for 2 min at room 
temperature and re-suspended in 1ml of TRIsure TM (Bioline US Inc) and transferred to a 2 
ml screw-capped tube containing MagNA Lyser Green Beads (Roche Diagnostics, 
Germany) then homogenized at 7,000 rpm for 40s in a Roche MagnaLyser and 
immediately chilled on ice. The lysate was centrifuged at 6000 x g for 3 min to pellet the 
beads and cell debris then the supernatant was transferred into the new tube. After adding 
200µl chloroform, the lysate was shaken vigorously for 15s, incubated at room 
temperature for 2 min then centrifuged at 12,000 x g for 15 min at 40C.  The aqueous 
phase was transferred carefully to a new tube, and the RNA was precipitated by adding 
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500 µl of isopropyl alcohol followed by centrifugation at 10,000 x g for 10 min at 40C. The 
RNA pellet was washed with 1ml of ethanol 75% and air-dried for 3h. 30 µl of DNase- and 
RNase-free water was added to re-suspend the pellet followed by storing at -800C for 
further study. 
Genomic DNA was digested using the RNAse-free DNAse set (Qiagen), RNA was 
quantified fluorimetrically using a Qubit fluorimeter (Life Technologies, Melbourne) and 
20ng per sample was used for cDNA synthesis with the QuantiTect® Reverse 
Transcription Kit (Qiagen®) in accordance with the manufacturer’s instructions.  
All real-time PCR experiments were performed in 384 well plates with reagents dispensed 
using an epMotion 5075 Robot (Eppendorf, Hamburg) and thermal cycling was performed 
with the ABI ViiA7 using SYBRGreen Master Mix (Applied Biosystems). The primers and 
input cDNA concentrations were optimized at 200nM and 1ng respectively per reaction to 
yield ~100% efficiency. In each reaction there were 0.2 µl of Forward primer, 0.2 µl of 
Reverse primer (both from 10 µM stock solutions), 5 µl of SYBRGreen Master Mix, 2 µl of 
cDNA 0.5ng/µl, and 2.6 µl of water. Cycling parameters were: 950C for 10 min followed by 
40 cycles of 950C for 15s and 620C for 1min, then a final melt curve at 950C for 15s, 600C 
for 1min and 950C for 15s. All temperature cycling was performed with acceleration at 
1.60C/s. 
2.2.4 Determination of plastic adherence with respect to growth phase 
Streptococcus iniae QMA0076 and QMA0248 were grown in THB at 280C over night to 
reach the stationary phase, then adjusted to OD600 ~ 1 and proceeded to the plastic 
adherence assay. Three cultures per strain were inoculated with a 2% v/v overnight culture 
in THB and incubated at 280C. These cultures were stopped at the desired time 
corresponding to mid-exponential, late-exponential, and stationary phases. The optical 
densities of these cultures were measured at 600nm and the OD of all cultures adjusted by 
dilution to be equivalent to the mid-exponential value. An aliquot (100 µl) of each sample 
transferred to the wells of a U-bottom 96-well plate (10 wells per treatment as technical 
replicates) and the cells brought into contact with the plastic by centrifugation at 500 x g for 
10 min. Plates were incubated at 280C for 0, 15 and 30 min then the supernatant was 
removed and plates were washed twice with water followed by addition of 100 µl 0.05% 
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Coomassie blue in 40% methanol, 10 % acetic acid at room temperature (RT) for 15min. 
Subsequently, the stain was removed and plates were washed with water three times 
before adding 200 µl  of 40 % methanol, 10% acetic acid  and incubating at RT for 15 min 
to resolubilise the bound dye prior to reading optical density at 620nm. 
2.2.5 Whole blood and serum bactericidal assays 
Starter cultures of S. iniae QMA0076 and QMA0248 were grown in THB overnight at 280C 
with shaking. Escherichia coli DH5α was also cultured as a susceptible control. Cell 
densities were adjusted to OD600 = 1, inoculated at 2% v/v into THB and incubated at 280C 
with gentle agitation. These cultures were then stopped at the time corresponding to the 
mid-exponential, late-exponential, and stationary phases. OD600 was then adjusted for 
each culture to the same optical density as the mid-exponential culture by dilution. Each 
sample was then diluted a further 2x104 times for the assay. Blood from juvenile 
barramundi was collected fresh as required aseptically by caudal venepuncture in 
heparinised syringes and diluted 1:1 in RPMI medium. Aliquots (50 µl) were distributed into 
the wells of a sterile 96-well U-bottom culture plate and 50 µL of each standardised cell 
suspension was added into 5 replicate wells per treatment (bacterial isolate and time point 
in the growth curve). The mixture was incubated at 280C for 30 min. Uninoculated blood 
was also incubated to ascertain sterility. Bacteria harvested at each of the three growth 
phases were incubated in THB (ie. No blood or serum) as normal growth controls. Number 
of surviving cells was determined by viable counting on THA. 
For serum bactericidal assays, the same protocols were followed with the following 
adjustments. In place of blood, heat-inactivated normal serum, heat-inactivated S. iniae 
QMA0248-anti serum prepared previously (Aviles et al., 2013), heat-inactivated normal 
serum supplemented fresh normal serum, and heat-inactivated S. iniae QMA0248-anti 
serum supplemented with fresh normal serum. Heat inactivation was by incubation at 560C 
for 30 min to inactivate all the complement proteins. The fresh normal serum was used as 
a homogeneous source of complement proteins between the assays. The four sera were 
diluted 1:1 with RPMI media and 100 µl distributed into the wells of a 96-well U-bottom 
plate with 15 µl of bacterial suspension as above and incubated at 280C for 30 min prior to 
enumeration by viable counting on THA.  All assays were repeated three times and 
representative data are presented. 
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2.2.6 Data analysis 
PCR efficiency for each primer set was determined with serial dilutions of cDNA samples 
from the four strains. The PCR exponential amplifications of these genes were calculated 
based on the slope estimated by Ct value of a serial dilution in the validation experiment 
against Log10 of the cDNA amount per reaction, described by E = 10-1/slope (Hellemans et 
al., 2007). Any variation in amplification efficiency was then accounted for during 
normalization of relative gene expression differences between the target group and the 
control group. The normalization factor was calculated based on the geometric mean of 
the relative quantities valued for three reference genes using REST (Pfaffl et al., 2002; 
Vandesompele et al., 2002). Ct data were analysed with REST based on the Pair Wise 
Fixed Reallocation Randomisation Test (Pfaffl et al., 2002), in which the normalized 
relative quantities were calculated based on the ratio of the group means for target gene 
against the normalized reference genes. The result represented the up- or down-regulation 
of the target group (i.e. late-exponential, or early stationary phase) compared to the control 
group (i.e. mid-exponential phase).  
Bacterial growth curves were analysed by non-linear regression based on the Gompertz 
equation (Mytilinaios et al., 2012). Differences in susceptibility of bacteria in whole blood 
and sera was analysed by t-test using Prism 6 for Macintosh (GraphPad Inc, California). 
2.3 Results 
2.3.1 ScpI and cppA are highly a conserved peptidase and metalloprotease 
respectively 
ScpI is a subtilisin-like serine protease comprising a pre-protein of 1122 aa with a 
predicted double arginine bacterial signal peptide cleavage site at residues 32 and 33. The 
mature peptide has a predicted molecular weight of 120 KDa and a pI of 4.86. There is a 
highly conserved c5 S8 peptidase domain between residue 65 and 539 of the mature 
monomer. A proline, leucine leucine polypeptide binding site was conserved with S. 
pyogenes C5a peptidase along with an active site triad at residues Asp114, His181 and 
Ser501 (82, 149 and 469 in the mature monomer)(Figure 8a). Two putative 
transmembrane helices were identified between residues 468-482 and 1070-1083, close 
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to the C terminus by Phyre2, but only the C terminus transmembrane helix was supported 
by the other two prediction models (TMHMM and psipred)(Figure 8a). 
CppA is small protein estimated at 28.1 KDa with two Glo-EDI-BRP-like metalloprotease 
active domains (Figure 8b). BLAST search revealed closest relationship with peptidase 
from S. parauberis, the C3-degrading proteinase from S. dysgalactiae, and the CppA N-
terminal domain from S. pyogenes (Figure 8b). No signal peptide was detected, nor were 
any potential transmembrane helices, beta barrel or Gram positive membrane anchor 
predicted (Figure 8b).  
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Figure 8. Amino acid sequences showing key features, predicted structure and 
phylogenetic position for scpI (a) and cppA (b). Conserved functional domains are 
highlighted in green; a) Peptidase S8 family domain in Streptococcal C5a peptidases and 
b) Glo_EDI_BRP_like metalloprotease domains. The transmembrane helix in scpI is 
highlighted in dark blue. ^Catalytic triad residues; #putative polypeptide binding site; 
*Putative active site. Phylogenetic relationships were inferred by maximum likelihood with 
the closes matches by BLAST. Bootstrap support values are indicated. 
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2.3.2 ScpI and cppA are coordinately but inversely regulated with cspE through the 
growth phases 
In order to investigate whether cps and the putative complement proteases are 
coordinately regulated, the effect of growth phase on expression was considered. First, 
growth curves were constructed for each of the bacterial isolates under the various culture 
conditions. From the curves potential transition points were identified for comparison of 
gene expression. Transition from log to stationary phase was identified in each curve and 
samples taken during mid-log as a reference, and then either side of point of inflexion in 
the growth curves (Appendix A). 
Expression of target genes was normalised against 3 reference genes and levels of gene 
expression were determined relative to expression during mid-log growth. Changes in 
expression are presented as Log2-fold changes (Figure 9). Streptococcus iniae isolates 
showed switching of gene expression between mid-log and late log, with scpI and cppA 
up-regulated approximately 2 fold whilst cpsE expression was downregulated 2 fold 
(Figure 9A). Once into stationary phase there was a second switching of expression, this 
time with cpsE up-regulated almost 8-fold in strain S. iniae QMA0248 and 2 fold in strain 
S. iniae QMA0076 (Figure 9). In contrast the expression of scpI was strongly down 
regulated with 2 fold reduced expression in strain S. iniae QMA0248 whist expression was 
down regulated more than 4 fold in strain QMA0076. There was no significant change in 
expression of cppA at this time (Figure 9).  
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Figure 9. Expression (normalized against three reference genes) of scpI, cppA, and cpsE 
at late exponential and stationary phase relative to mid-exponential phase in Todd-Hewitt 
Broth. (A)QMA0248, (B) QMA0076 (Mean ± SD, n = 9; *p<0.05; ***p<0.001) 
 
 
2.3.3 Cell adherence is affected by growth phase 
The adherence of S. iniae to plastic following 15 min incubation (< 1 generation time) was 
determined in 96 well plates and was consistent between isolates (Figure 10). The number 
of adherent bacteria was plotted relative to the mid-exponential value to determine how 
adherence changed with the growth phase of the inoculum. There was significant increase 
in adherence between mid and late log phase, whilst adherence decreased significantly in 
stationary phase (Figure 10).  
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Figure 10. Surface adherence of S. iniae to plastic at different phases of growth. (A) S. 
iniae QMA0248, (B) S. iniae QMA0076. (Mean ± SD, n = 3; **p<0.01; ***p<0.001) 
 
2.3.4 S. iniae growth and survival in whole blood and serum is affected by growth 
phase of the inoculum 
The susceptibility of bacteria from each sample point in the growth phase to whole blood 
killing in terms of percentage survival after 30 min incubation was determined (Figure 11). 
The susceptibility pattern of S. iniae was consistent between both strains. The mid-
exponential sample went through one doubling in population during the 30 min incubation 
in whole blood whilst the late exponential sample was significantly killed (Figure 11). Cells 
from stationary phase did not grow in the blood within the 30 min incubation employed 
during the assay (Figure 11). The control E. coli DH5a was killed by 30 min incubation in 
whole barramundi blood (not shown).  
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Figure 11. Survival of S. iniae QMA0248 (A) and QMA0076 (B) over 60 min in whole 
barramundi blood when a standardised number of cells from different growth phases are 
used as the starting inoculum. The survival percentage of each growth phase was 
estimated based on the number of colony forming units before and after incubation for 60 
min at 28°C (Mean ± SD, n = 3; significant difference indicated by different letters, p<0.05). 
 
The ability of S. iniae strain QMA0248 to grow in serum and antiserum was analyzed with 
and without complement proteins by supplementing heat inactivated sera with fresh 
normal serum as a source of heat labile proteins (Figure 12). In heat inactivated normal 
serum, cells harvested at mid-exponential phase grew, approximately doubling in 30 min 
incubation (Figure 12). Cells harvested later in the growth phase did not divide in serum 
over the 30 min period. Presence of specific antibody appeared to inhibit growth in serum 
using mid-exponential inoculum, and there was significant killing of bacteria by antiserum 
when the cells used in the inoculum were harvested at mid or late exponential phase 
(Figure 12), regardless of the phase of growth or the  (Figure 12). Surprisingly, addition of 
fresh serum increased growth in both normal serum and antiserum, with only cells 
harvested in stationary phase either inhibited or killed (Figure 12).   
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Figure 12. Survival of S. iniae QMA0248 in barramundi serum using inocula from different 
growth phases. HINS: heat-inactivated normal serum, HIAS: heat-inactivated anti-
QMA0248 antiserum, HINS+FS and HIAS+FS: heat-inactivated normal serum or 
antiserum with fresh serum added as a uniform source of complement and other heat-
labile plasma proteins (Mean ± SD, n = 3; *p<0.05; **p<0.01; ***p<0.001) 
 
2.4 Discussion 
Bacterial pathogens that cause septicaemia, such as the fish pathogen S. iniae must 
survive and replicate in the blood in order to disseminate through the host and therefore 
must be resistant to a range of host innate defences. Many bacteria that cause 
septicaemia express polysaccharide capsules as key virulence factors (Cunningham, 
2000; Glauser et al., 1991), including S. iniae (Barnes et al., 2003). However, resistance 
mechanisms such as extracellular polysaccharide capsule may lead to a trade-off in ability 
to attach and invade into other organs and tissues (Hammerschmidt et al., 1996; St Geme 
and Falkow, 1991; Vogel et al., 1996). This is counter to the pathology of S. iniae which 
invades the central nervous system and therefore must attach and traverse the blood brain 
barrier, implicating down-regulation of CPS during invasion, which may leave the pathogen 
susceptible to host defences. Here I investigated whether CPS expression in S. iniae is 
coordinately regulated with alternate factors that may protect from innate immune defence 
in the absence CPS expression. I employed the gene cpsE, a putative transferase in the 
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cps operon, as a proxy for CPS expression and investigated how this was regulated 
through the growth phase in comparison to two putative complement proteases, cppA and 
scpI. In S. iniae cps expression is regulated through the growth phase with down 
regulation towards the end of exponential growth and up-regulation once in stationary 
phase where rates of cell death and cell division are equal. Interestingly, the C5a protease 
gene scpI was inversely regulated suggesting potential coordinate regulation to provide 
protection against complement activity when CPS expression is low, perhaps permitting 
improved attachment at appropriate triggers without sacrificing complement resistance. It 
is highly likely that multiple interacting factors effect regulation of these systems during 
growth phase; for example elevated CO2, superoxide level, oxygen level, and other metal 
ions such as zinc or manganese (Kreikemeyer et al., 2003). Further work is required to 
determine what factors in the host may regulate this switch.  
The susceptibility of S. iniae to host humoral innate immunity over the growth phases was 
investigated in vitro by whole blood and serum killing assay. Although the susceptibility of 
S. iniae to whole blood killing over the growth phases was varied, the general pattern was 
consistent between strains (Figure 11). Generally, mid exponential phase inoculation 
resulted in growth in blood over the incubation period. This is largely in agreement with 
previous research in which virulent S. iniae recovered from mid-exponential culture grew 
rapidly in whole blood, increasing approximately 5-fold after 1 h incubation (Buchanan et 
al., 2008). However, inhibition of growth of S. iniae by whole blood has also been reported 
in which the survival of mid exponential S.iniae strain 9033 was only 77% after 1.5 h of 
incubation (Fuller et al., 2001), these apparently contrasting observations may result from 
the difference in the incubation time that provided the bacteria enough time to transform to 
the next growth phase. This hypothesis is supported by our results, in that the survival of 
the late log sample dramatically declined from high resistance detected in the mid log 
sample. The reduction of the ability to avoid phagocytosis when the capsule is down-
regulated is also consistent with previous studies that a capsule deficient mutant was 
susceptible to the blood (Locke et al., 2007). In the serum bactericidal assay resistance to 
serum killing generally declined over the growth phases. In heat inactivated antiserum, 
growth was restricted regardless of the growth phase of the inoculum, compared to heat-
inactivated normal serum. Surprisingly, when specific antiserum was supplemented with 
fresh serum as a source of complement and other heat-labile plasma proteins, 
growth/survival increased compared to heat inactivated antiserum alone, regardless of 
  Coordinate Inverse Regulation 
 
 [35]  
growth phase of the inoculum.  Streptococcal complement proteases can have multiple 
functions. The C3b-degrading proteinase SpeB in GAS can interact with a broad range of 
molecules including cleavage of antibodies at the hinge region once they bind to antigens 
on the surface of S. pyogenes (Söderberg et al., 2008). Furthermore, this protease can 
also hydrolyse and destroy chemokines, which are secreted by inflamed epithelial cells, 
and are responsible for signalling and antibacterial activity (Egesten et al., 2009). It can 
also induce inflammation by cleaving pro-interleukin-1β into active form interleukin-1β 
(Kapur et al., 1993a), hydrolysing H-kininogen into bradykinin (Herwald et al., 1996), 
inducing histamine release and mast cells degranulation (Watanabe et al., 2002), which 
enhances S. pyogenes infection. It is likely SpeB is an important part of the multi-target 
invasion strategy of GAS as it effectively degrades innate immune barriers including 
fibrin/fibrinogen in blood coagulation (Elliott, 1945; Matsuka et al., 1999), antigen-bound 
plasmin (Svensson et al., 2002), extracellular matrix proteins vitronectin and fibronectin 
(Kapur et al., 1993b); and indirectly participates in tissue degradation and apoptosis 
(Burns et al., 1996; Tamura et al., 2004). In terms of complement pathway corruption, 
mature SpeB can cleave the C3 component and prevent the formation of the C5 
convertase complex (Kuo et al., 2008; Terao et al., 2008). The cleavage of C3 leads to 
failure of opsonizing bacteria by C3b, which prevents the formation of extreme pro-
inflammatory mediator C5a, the assembly of MAC and ultimately phagocytosis by 
neutrophils. In addition, mature SpeB also can lyse Properdin, a protein that enhances the 
stabilization of the C5 convertase complex in the alternative pathway (Tsao et al., 2006) 
leading to a labile complex, which is subsequently inactivated. Therefore, these 
complement proteases in Streptococcal species do not only possess C5a and C3 
cleavage ability, but also interact with other molecules to escape phagocytic clearance. 
Alternate functions of scpI and cppA require further investigation in fish models 
In the blood, virulent Streptococcus cause septicaemia, but capsule-deficient mutants 
preferably enter CNS instead of remaining in the blood stream (Doran et al., 2005; Martins 
et al., 2010; Millard et al., 2012; Morona et al., 2006). The successful adherence and 
invasion of meningeal pathogens with ineffective capsules (Doran et al., 2005; Hook et al., 
1975; Monsinjon et al., 2001; Nizet et al., 1997; Nonaka et al., 1985) shows that 
pathogens have an alternative strategy, including potentially complement proteases, which 
protects them from host phagocytosis and other immune defences, C3-degrading protease 
cppA has been reported in S. iniae (Zhang et al., 2014), S. pneumoniae (Angel et al., 
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1994), S. dysgalactiae subsp. dysgalactiae (Rato et al., 2011) and it can degrade and 
inactivate soluble C3. C5a peptidase Scp can cleave C5a at the binding site for 
polymorphonuclear leukocytes, resulting in the slowdown of influx of polymorphonuclear 
neutrophil leukocytes through failure of chemotactic signalling and neutrophil attraction to 
the infection site (Angel et al., 1994; Cleary et al., 2004). However, the up regulation of 
scpI during late exponential phase in this study did not fully protect S. iniae in whole blood, 
where neutrophils are likely to be the major means of killing activity. This role for 
neutrophils is supported here as S. iniae from late exponential phase were able to grow in 
cell free HI-NS and HI-NS + fresh serum suggesting high resistance to complement and 
other humoral factors.  Both Group A and B Streptococci possess the mechanism to 
escape from phagocytosis, and clearance of GAS at the infection site is delayed when Scp 
is expressed on its surface (Hung et al., 2012). Additionally, Scp acts as an adhesin to 
Fibronectin type III and enhances invasion to epithelial cells (Beckmann et al., 2002). 
Interestingly, anti-ScpB antibody opsonizes GBS across serotypes, resulting in increased 
killing rate and macrophage oxidative burst (Cheng et al., 2001).  
In order to tease out the roles of scpI and cppA in S. iniae virulence, knockout mutants 
should be prepared. Indeed an scpI knockout has been investigated previously and did not 
reduce virulence in hybrid striped bass challenge model (Locke et al., 2008). It is intriguing 
to speculate why this gene should be retained, and functionally regulated if it plays no role 
in survival in the host. As the challenge models in the previous study were by 
intraperitoneal (IP) and intramuscular (IM) injection, it may be that scpI is required early as 
it translocates from the environment into the host. Moreover, the inoculum for the 
phenotypic assays in the Locke’s study was at the mid-log phase where scpI is down 
regulated. In addition, cppA may inactivate the complement system upstream of the C5a 
peptidase (Locke et al., 2008), and I have shown here that these genes are regulated 
together over the growth phases. However, I remain to be convinced that cppA is a 
complement degrading protease due to its predicted cytoplasmic location, although in 
silico predictions have limitations. Therefore, dual and single knock out isogenic mutants 
should be investigated in virulence models to determine their role in pathogenesis. 
In conclusion, coordinate inverse regulation of cps and complement proteases appears to 
occur in marine pathogenic S. iniae with regulation occurring by growth phase. However 
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phase regulation is multifactorial and complex. Further investigation is required to 
determine specific triggers of this regulation that may apply in the host during infection. 
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3. Chapter III. Role of complement proteases in fish pathogenic 
Streptococcus iniae  
3.1 Introduction 
In the previous chapter, the susceptibility of wild type S. iniae to host humoral innate 
immunity over the growth phases was investigated in vitro by whole blood and serum 
killing assay. Generally, mid exponential phase inoculation resulted in growth in fresh 
barramundi blood over the incubation period, while an inoculum derived from late-
exponential phase was susceptible to killing (Chan N. Dieu, 2015). To determine whether 
neutrophils or plasma factors were involved I also investigated growth and survival in cell 
free serum in the presence and absence of specific antibody and heat labile plasma 
factors. The results were complex showing an effect of antibody in heat inactivated serum 
but, surprisingly, increased growth in serum when fresh serum was added as a source of 
complement (Chan N. Dieu, 2015). To further elucidate the trade off between complement 
proteases and capsule, particularly during late-exponential phase of growth, I prepared 
isogenic knock out mutants of both proteases in our virulent model strain S. iniae 
QMA0248. An scpI knockout has been investigated previously and did not reduce 
virulence in hybrid striped bass challenge model (Locke et al., 2008): Indeed, Locke’s 
∆scpI mutant of strain K288 conserved the phenotypic properties of the wild type S.iniae 
including the coccoid morphology, cell buoyancy and cell surface charge, and haemolytic 
activity against fish red blood cells. However, K288∆scpI produced a higher proportion of 
multimeric cocci chains than the wild type (Locke et al., 2008). The precise in-frame allelic 
replacement of scpI in K288 did not reduce virulence in a hybrid striped bass IP challenge 
model (p=0.31), but was possibly involved in the change in killing rate in the intramuscular 
injection (IM) challenge model (p<0.01). In the zebra fish IM challenge model, although the 
mortality following challenge with K288∆scpI occurred later compared to fish challenged 
with the wild type, there was no significant difference in final mortality (p=0.985). 
Therefore, these authors concluded scpI was not required for virulence in fish when 
delivered by injection (Locke et al., 2008). This lack of conclusive phenotype in the in vitro 
phenotypic assays may result from the inoculum in Locke et al ’s study being mid-log 
phase where scpI is not highly expressed relative to either capsule or reference genes 
(Chan N. Dieu, 2015). Moreover, IP- and IM-injection routes in Locke’s challenge model 
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might ignore the role of ScpI during the early stages of translocation from the environment. 
The role of Scp in the inhibition of leukocyte chemotaxis has been reported in other 
Streptococci (Cleary et al., 1992; Hill et al., 1988). Additionally, the effect of scpI deletion 
may be masked by the activity of C3-degrading protease CppA which inhibit complement 
deposition and signalling further upstream from C5a (Locke et al., 2008). Indeed, I have 
shown that the expression of these two proteases is regulated together over the growth 
phases (Chan N. Dieu, 2015). Therefore, further study of knock out mutants of these 
genes is warranted to understand the roles of these complement proteases in resistance 
to the host innate immune system in vitro and how their expression may compensate for 
down regulation of capsule during the attachment phase of infection. 
3.2 Materials and methods 
3.2.1 Bacterial strains and culturing 
S. iniae strains QMA0248 and QMA0076 (Aviles et al., 2013) were stored in Todd-Hewitt 
broth (THB) containing 20% glycerol at -800C. Isolates were cultured routinely on sheep 
blood agar plates (Oxoid, Australia) at 280C for 12-24h. For broth starter cultures, a single 
colony was used to inoculate Todd-Hewitt broth and incubated at 280C with gentle 
agitation for 12-18 h. 
3.2.2 Isogenic knock-out mutants  
Isogenic knock-out mutants ∆scpI and ∆cppA in QMA0248 were prepared by allelic 
exchange mutagenesis using the spectinomycin resistance (aad9) gene from pBBR1MCS-
5 (LeBlanc et al., 1991) (Figure 13). Primers for PCR were designed to amplify ≈1000 bp 
upstream and ≈1000 bp downstream of S. iniae chromosomal DNA flanking regions of the 
scpI and cppA genes. The 3’-end of the reverse primer of the upstream flanking region and 
the 5’-end of forward primer of the downstream flanking region contained a 3’ overhang 
and 5’ overhang respectively consisting of 25 bp complementary to the 5’ region or 3’ 
region of the aad9 spectinomycin resistance gene. The primer sequences are listed in the 
Appendix B.  
The upstream and downstream fragments were combined with the 753 bp aad9 gene by a 
three-way fusion PCR. The fusion PCR reaction comprised 2 µl of 50mM MgSO4, 10 µl of 
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5X PCR Buffer (Platinum Pfx kit, Invitrogen), 10 µl of 10mM dNTPs, 200 ng of upstream 
fragment, 200 ng of downstream fragment, 200 ng of aad9 fragment, brought to a volume 
of 43.5 µl with sterile ultra-pure water. Fusion of fragments was initiated at 940C for 3 min, 
followed by 10 cycles of 940C for 1 min, 450C for 2 min, 720C for 3 min, and cooling to 
100C. After these 10 cycles, 1 µl of 10µM 5’- upstream flanking region forward primer, 1 µl 
of 10µM 3’- downstream flanking region reverse primer, 2 µl of DMSO, and 0.5 µl of 
Platinum Pfx polymerase were added. Then further cycling was performed at 940C for 3 
min, followed by 35 cycles of 940C for 1 min, 520C for 30 s, and 680C for 5 min. Final 
extension was carried out at 680C for 10 min. The fusion product was gel-purified and 
cloned into a pCRTMII-Blunt-TOPO vector (InvitrogenTM) and chemically transformed into 
TOP10 E. coli competent cells (InvitrogenTM) following the protocol supplied with the Zero 
Blunt TOPO PCR Cloning Kit. Positive clones were selected on LB-Kanamycin (50µg/ml) 
plate and submitted to colony PCR and sequencing to confirm integrity of the fusion 
product. 
 
 
Figure 13. Isogenic mutagenesis knock out mutants diagram of (A) scpI and (B) cppA in S. 
iniae. Spectinomycin encoding gene aad9 was introduced into the wild type genome of S. 
iniae by allelic exchange mutagenesis between the homologous up- and down-stream 
flanking regions. (Locke et al., 2008). 
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Plasmid DNA from the positive transformants was isolated using a modification of the 
alkaline lysis method previously described (Birnboim, 1983). Briefly, positive colonies were 
grown at 370C overnight in LB supplemented with Kanamycin 50 µg/ml and cells were 
harvested and re-suspended in 100 µl of re-suspension buffer comprising 50mM glucose, 
10mM EDTA, 25mM Tris at pH 8.0. The suspension was lysed with 200 µl of lysis buffer 
(0.2N NaOH and 1% SDS), neutralized with 200 µl of 3M Potassium acetate at pH 6.0. 
The mixture was not vortexed to avoid disrupting the chromosomal DNA. The lysate was 
precipitated by adding 1ml isopropanol followed by incubating at -800C for 30 min to 
enhance the DNA precipitation. The plasmid was harvested by centrifuging at 13,500 rpm 
in an Eppendorf minispin at 40C for 5 min, subsequently washing with 70% EtOH followed 
by harvesting at 13,500 rpm at 40C for 3min in an Eppendorf minispin centrifuge. The 
plasmid was air-dried and re-suspended in 50 µl TE. Two hundred micrograms of 
recombinant plasmid was linearized by digestion with 20 units of restriction enzyme PstI at 
370C for 12 h then purified by salting out with 50 µl of 3M Sodium acetate. The plasmid 
was then precipitated with 2ml isopropanol followed by incubating at -800C for 30 min and 
harvesting by centrifuging at 13,500 rpm in an Eppendorf minispin at 40C for 5 min, 
subsequently washing with 70% EtOH followed by harvesting at 13,500 rpm at 40C for 
3min in an Eppendorf minispin centrifuge. 
Ten micrograms of the linearized knockout plasmid was introduced to S. iniae QMA0248 
competent cells by electroporation (Framson et al., 1997; Locke et al., 2007). The colonies 
that contain pKOscpI (or pKOcppA) were identified by spectinomycin selection (100µg/ml) 
on THA. Successful knockout mutation was confirmed by colony PCR and sequencing of 
the targeted in-frame replacement of scpI (or cppA) by aad9 gene (Figure 13). Knockout 
mutants were employed in serum and whole blood killing assays as described below. 
3.2.3 β-hemolysis sheep red blood cells 
The hemolysis assay was performed essentially as previously with minor modification 
(Locke et al., 2008). The sheep whole blood (Oxoid, Australia) was centrifuged at 500 x g 
for 10 min at 40C. Subsequently, 1ml of pellet was re-suspended with 3ml of HEPES-NaCl 
wash solution (HEPES 20mM, NaCl 0.9%) and cells collected at 1000 x g for 30 min at 
40C followed by discarding the supernatant. This washing step was repeated three times 
or until the supernatant became clear. Red blood cells (RBCs) were then centrifuged at 
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1000 x g for 5 min at 40C to pack the cells then a 2% (v/v) working suspension was 
prepared by adding 100 µl of packed cells into 4.9 ml phosphate buffered saline (PBS). In 
a 96-well U-bottom microtitre plate, 150 µl of mid log culture of S. iniae QMA0248 wild 
type, ∆scpI and ∆cppA was deposited into each well with 10 replicates per isolate, to which 
150 µl of the RBC suspension was subsequently added. The positive control of completely 
lysed cells comprised 148.5 µl of THB, 148.5 µl of RBCs 2%, and 3 µl of Triton X-100, 
whilst the blank contained 150 µl THB and 150 µl RBC suspension. The plate was 
incubated at 280C for 2 h then at 40C for 2 h, followed by centrifugation at 1,500 x g for 5 
min. An aliquot (200 µl) from each well was transferred to a new 96-well plate and the 
optical density was read at 405 nm.   
3.2.4 Survival of ΔscpI and ΔcppA in whole barramundi blood 
Starter cultures of S. iniae QMA0248 wild type, ΔscpI and ΔcppA were grown in THB 
overnight at 280C with shaking. E.coli DH5α was also cultured as a susceptible control. 
Cell densities were adjusted to OD600 ~ 1, inoculated at 2% v/v into THB and incubated at 
280C with gentle agitation. These cultures were then stopped at the time corresponding to 
mid-exponential and late-exponential phases. OD600 was then adjusted for each culture to 
the same optical density as the mid-exponential culture by dilution. Each sample was then 
diluted a further 2x104 times for the assay. Blood from juvenile barramundi was collected 
fresh as required aseptically by caudal venepuncture in heparinised syringes and diluted 
1:1 in RPMI media. Aliquots (50 µl) were distributed into the wells of a sterile 96-well U-
bottom culture plate and 50 µL of each standardized cell suspension was added into 5 
replicate wells per treatment (bacterial isolate and time point in the growth curve). The 
mixture was incubated at 280C for 30 min. Uninoculated blood was also incubated to 
ascertain sterility. Number of surviving cells was determined by viable counting on THA. 
3.2.5 Susceptibility of ΔscpI and ΔcppA to killing by serum and antiserum 
For serum bactericidal assays, the same protocols were followed with the following 
adjustments. In place of blood, heat-inactivated normal serum, heat-inactivated S. iniae 
QMA0248-anti serum prepared previously (Aviles et al., 2013), heat-inactivated normal 
serum supplemented fresh normal serum, and heat-inactivated S. iniae QMA0248-anti 
serum supplemented with fresh normal serum. Heat inactivation was by incubation at 560C 
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for 30 min to inactivate all the complement proteins. The fresh normal serum was used as 
a homogeneous source of complement proteins between the assays. The four sera were 
diluted 1:1 with RPMI media and 100 µl distributed into the wells of a 96-well U-bottom 
plate with 15 µl of bacterial suspension as above and incubated at 280C for 30 min prior to 
enumeration by viable counting on THA.  All assays were repeated three times and 
representative data are presented. 
3.2.6 Statistical analysis 
Differences in haemolytic activity were analysed by one-way ANOVA, and differences in 
susceptibility of bacteria in whole blood and sera were analysed by two-way ANOVA using 
Prism 6 for Macintosh (GraphPad Inc, California). 
3.3 Results 
3.3.1 Hemolytic activity of knock-out mutants ΔscpI and ΔcppA was lower than 
wild type 
Although the haemolytic activity of knock out mutants was lower than wild type, their 
values ranged broadly and some samples were equal to or higher than the wild type 
(Figure 14). The haemolytic activities of two knock out mutants were similar and their 
differences compared with wild type were marginally non-significant (p=0.0575 and 
p=0.0594, respectively). 
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Figure 14. Haemolytic activity of QMA0248 wild type, ΔscpI and ΔcppA against sheep red 
blood cells. Positive control (n=3) was completely lysed by adding Triton X-100. (Mean ± 
SD, n = 10; *p<0.06) 
 
3.3.2 Knock-out mutants ΔscpI and ΔcppA did not grow in whole blood  
The survival of the wild type QMA0248 in whole blood was consistant with our previous 
reports. Briefly, the mid-exponential inoculum doubled within the 1 h incubation, whereas 
the late log inoculum resulted in modest killing (76% survival during 1 h incubation)(Figure 
15). In contrast, mid-log inocula of the knockout mutants ΔscpI and ΔcppA were static or 
marginaly killed by whole blood (104% and 88% respectively)(Figure 15).  Intriguingly, 
while the susceptibilities of WT and ΔscpI mutant during late log phase were similar, 
ΔcppA was more resistant with some growth in whole barramundi blood (survival = 124%, 
Figure 15).  
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Figure 15. Survival of QMA0248 wild type, ΔscpI and ΔcppA, at different growth phases in 
barramundi whole blood. (Mean ± SD, n = 3; **p<0.01; ****p<0.001) 
 
3.3.3 Knock-out mutans ΔscpI and ΔcppA are susceptible to host complement 
As with previous results (Chan N. Dieu, 2015) the wild type S. iniae QMA0248 grew rapidly 
in serum, more than doubling in cell number during the 30 min incubation, regardless of 
growth phase of the inoculum, although growth was less rapid in antiserum compared to 
normal serum (Figure 16 A, B). Growth of the knockout mutants was significantly restricted 
in heat-inactivated normal serum (HINS) compared to wild type (Figure 16A), and was 
similar to HINS in HIAS, but not significantly different to the wild type (Figure 16B). When 
fresh serum was added to HINS as a source of complement and other heat labile plasma 
proteins, the growth of WT was lower than detected in HINS alone (Figure 16 A, C), but 
there was no significant difference between WT and either KO mutant. Interesting growth 
of d-cppA was significantly increased compared to d-scpI. In contrast when FS was added 
to NIAS growth of both knockouts was severely depleted compared to WT (Figure 16D).  
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Figure 16. Growth or survival of QMA0248 wild type, ΔscpI and ΔcppA inoculated at 
different growth phases into (A) normal serum, (B) anti-QMA0248 serum, (C) normal 
serum with fresh serum added, and (D) anti-QMA0248 antiserum with fresh serum added. 
(Mean ± SD, n = 3; * p<0.05; **p<0.01; ***p<0.005; ****p<0.001) 
 
3.4 Dicussion 
The susceptibility of S. iniae to host humoral innate immunity over the growth phases 
investigated by whole blood and serum killing assay reported in our previous paper 
implicated a trade-off between the expression of capsule and putative complement factor 
proteases during late log phase (Chan N. Dieu, 2015). Survival in whole blood reflects the 
susceptibility to the total bactericidal activity of both humoral and cellular components e.g. 
neutrophils, thrombocytes, macroglobulins, lectins and the complement cascade. In 
contrast, comparison between heat-inactivated serum and HI serum with fresh serum 
added as a uniform source of complement is indicative of susceptibility to complement. 
Therefore the serum resistance of late Log phase inocula (capsule expression reduced) is 
suggestive of a role for complement proteases in complement resistance, and therefore 
virulence. Interestingly, a previous study using ΔscpI indicated no reduction in virulence in 
a hybrid striped bass and zebra fish challenge model by IP and IM routes (Locke et al., 
2008). These authors speculated on the possible role of other complement proteases to 
explain the lack of effect of the ΔscpI knockout (Locke et al., 2008). In my study I explored 
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the effect of deletion each of two complement proteases, ΔscpI and ΔcppA and found 
them more susceptible compared to the wild type to the host humoral innate immunity in 
vitro. Heat inactivated (HI) normal serum supplemented with fresh serum (FS) is likely to 
enable both the lectin pathway and the alternative pathway (Mayilyan et al., 2008). While 
the growth/survival of the ΔscpI KO mutant were not substantially affected by addition of 
FS to HINS, growth of the WT was reduced compared to HINS alone (Figure 16A, C), and 
the ΔcppA mutant, inoculated at mid-log inoculum grew more rapidly in HI normal serum 
when FS was added (Figure 16C). These results suggest that these proteins are not 
involved in resistance to complement activated via either the lectin or alternative pathway. 
Heat inactivated antiserum contains specific antibodies (detected by ELISA) against the 
WT S. iniae QMA0248. Addition of FS to HIAS will mean that the classical complement 
pathway is also active in addition to the lectin and alternative pathways. In HIAS without 
FS, growth of WT was restricted compared with HINS, so antibody has a direct role in 
restricting growth of WT S. iniae even in the absence of either cells or complement. I 
stress that this is inhibition of growth, rather than direct killing as survival was still in 
excess of 100% of the inoculum, and this may be due to direct blocking of processes vital 
to nutrient acquisition etc. thereby restricting growth and cell division. The knockout of 
either scpI or cppA had no significant effect on growth of S. iniae in HIAS (Figure 16B). In 
HIAS + FS, the growth of the knock-out mutants was significantly restricted compared to 
the wild type regardless growth phases, with 50% killing evident in mid-log phase (Figure 
16D).  This is surprising as I have previously shown that these genes are down regulated 
during high capsule expression in mid log phase relative to late log phase, yet the 
knockout impacted survival regardless the growth phase. This may reflect the fact that 
down regulation is not the same as complete deletion and that there is likely to be some 
basal expression of the proteases during down regulation. In contrast, the knockout 
mutants will not express the proteases at all and this may not only increase susceptibility 
to innate immunity, but generally, also have pleiotropic effects because these proteases 
may have multifactorial roles in growth and survival. It is highly likely that the scpI and 
cppA have roles in either modification of the bacterial cell surface, thereby reducing 
antibody cross reactivity, directly interact with antibody preventing binding or activation of 
the classical pathway. C3-degrading protease SpeB may also selectively cleave antibodies 
at the hinge region once they bind to antigens on the surface of S. pyogenes (Söderberg 
et al., 2008), cleave pro-interleukin-1β (Kapur et al., 1993a), hydrolyze H-kininogen 
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(Herwald et al., 1996), induce histamine release and mast cells degranulation (Watanabe 
et al., 2002) which enhances S. pyogenes infection. It is therefore worth conducting an in 
vivo challenge model with Barramundi Lates calcarifer employing these mutants to 
determine whether there is an effect on virulence in this host-pathogen model. Moreover a  
dual knock out mutant should be investigated to determine any interaction between these 
proteases, and amongst the intermediates of complement cascade. Perhaps most 
importantly, determining any the activity of recombinant scpI and cppA against a range of 
complement factors and antibody should be investigated as bacteria can take advantage 
of the complement-regulatory proteins of the infected host to interfere with the complement 
system of that host. For example, host complement factor H is a crucial inhibitor of the 
alternative complement pathway (Müller-Eberhard and Schreiber, 1980). In the absence of 
specific antibodies, factor H binds to the sialic acid capsule and Streptococcal M protein of 
the bacteria to protect them from the alternative complement pathway (Brown et al., 1983; 
Giannakis et al., 2003). The binding of fH to M protein on the Streptococci surface 
prevents the formation of C3 convertase C3bBb (Jones and Fischetti, 1988), and acts as 
the cofactor for factor I to degrade C3b as well as stimulates the dissociation of factor B 
from C3- and C5-convertases (Lars et al., 2002). In addition, factor H can bind to the 
integrin Mac-1 (CD11b/CD18), which promotes the response activity of neutrophils 
(DiScipio et al., 1998). Intriguingly, factor H is still retained in the serum heated at 560C for 
30min (Ram et al., 1998). Therefore the presence of factor H might help our protease 
knock out mutants survived in heat-inactivated sera (with out complement activities) 
(Figure 16A, B) and were slightly resistant to the serum killing in HINS+FS (Figure 16C). A 
protein equivalent to the M-protein of S. pyogenes, SiMA has previously been 
characterized in S. iniae (Baiano et al., 2008), and reduces phagocytosis and respiratory 
burst in fish macrophages. Binding of factor H to S. pyogenes was dependent on the 
hypervariable region of different M proteins, yet this interaction was not sufficient to confer 
complement resistance on the pathogen (Gustafsson et al., 2013). In S. pneumoniae, 
factor H-binding is inversely correlated with factor B-binding, C3b deposition, and 
neutrophil clearance, and is closely associated with the capsular serotypes and increased 
invasion (Hyams et al., 2013). In addition to factor H, others complement-regulatory factors 
may be recruited by pathogenic bacteria. For example, CD46 plays as a keratinocyte 
receptor of the bacterial M protein (Okada et al., 1995); C4b-binding protein (C4BP), an 
inhibitor of both classical and lectin pathways, is also bound by M protein in S. pyogenes 
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(Thern et al., 1995).  The binding of M proteins to C4BP as well as factor H cause the 
increased invasiveness of the pathogen (Blom et al., 2009), but S. iniae equivalent of this 
protein was not effective as a vaccine target in fish (Aviles et al., 2012). 
In conclusion, although the single isogenic knock out mutants ΔscpI and ΔcppA had 
apparently lower fitness in whole blood and serum than the wild type at both mid- and late-
log phases, the interaction between these proteases and others in the complement system 
is complex and requires further investigation. In order to understand how these proteases 
are involved in the breaking down the host complement pathway, a complement fixation 
assay should be conducted. Finally, a rescue of these genes in the knockouts should be 
performed to demonstrate that the rapid growth in blood and serum can be restored and to 
confirm their roles in S. iniae pathogenesis. 
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4. Chapter IV. Effect of iron limitation on the coordinate regulation of 
complement proteases and capsule in streptococcus iniae 
4.1 Introduction 
The process of pathogenesis of S. iniae from its environmental niche outside the host 
through septicaemic dissemination followed by attachment and transit across the 
microvascular endothelium into the host meninges will necessitate crossing through 
several different and continuously changing environments to which the pathogen needs to 
adapt. During all of these phases, resistance to host innate immunity will be critical, 
therefore the regulation of virulence genes involved in resistance coordinated with 
requirements for colonization will be required. Whilst the broad range of changes 
encountered in closed laboratory culture through growth provide a widely inclusive model 
for study, changes in the host environment that lead to specific gene regulation are also 
likely to be quite specific. These may include, for example, trace elements, i.e. iron, 
magnesium, zinc, copper, cobalt that have been demonstrated to play an important role in 
the regulation of gene expression. During infection, Streptococcal pathogens must acquire 
the essential elements, in an environment where they are rare or withheld tightly by the 
host. However some of these essential elements may be harmful in high concentration 
(eg. Copper and iron) therefore proper regulation of metal homeostasis is required 
(Higgins, 2001). For example, membrane bound metal transporters MtsABC in S. 
pyogenes in which iron and zinc ion are the two essential ligands (Janulczyk et al., 1999), 
PsaA in S. pneumonia translocates manganese ions (Dintilhac et al., 1997) and is also 
required for virulence (Berry and Paton, 1996) and a potential vaccine candidate 
(Talkington et al., 1996). As iron acquisition has a pivotal influence on pathogenesis 
(Ratledge and Dover, 2000), the regulation of intra- and extra-cellular iron accumulation, 
and effect of iron limitation on the expression of virulence factors has been widely 
investigated (Griffiths and McClain, 1988; Smoot et al., 2001b).  For example, key 
virulence factors such as M proteins (Aviles et al., 2013; McIver et al., 1995), cysteine 
proteases, serine proteases belonging to the same family as scpI (Allard et al., 2006) are 
up-regulated under iron limitation.  
Since expression of the complement proteases and capsule is coordinately regulated over 
the growth phases (Chan N. Dieu, 2015), and the iron is always withheld tightly by host 
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high-affinity iron binding proteins such as haemoglobin, lactoferrin and transferrin (Cassat 
and Skaar, 2013), in this study I aim to investigate the effect of iron limitation on this 
regulation of scpI, cppA and capsule at different points of the growth curve. 
4.2 Materials and methods 
4.2.1 Bacterial strains and culturing 
Streptococcus iniae strains QMA0248 and QMA0076 (Aviles et al., 2013) were stored in 
Todd-Hewitt broth (THB) containing 20% glycerol at -800C. Isolates were cultured routinely 
on sheep blood agar plate (Oxoid, Australia) at 280C for 12-24 h. For broth starter cultures, 
a single colony was used to inoculate Todd-Hewitt broth and incubated at 280C with gentle 
agitation for 12-18 h. For growth curves, 30 µl aliquots taken from overnight broth cultures, 
measured the optical density (OD) at 600 nm and adjusted to 1.0, were used to inoculate 
1470 µl fresh THB in 24 well tissue culture plates. Growth was recorded by measuring 
optical density 600 nm over time using a POLARstar Omega Microplate Reader (BMG 
Labtech, Melbourne). Mid-exponential, late exponential, and stationary phases were 
determined from at least three replicate experiments with each plate incorporating un-
inoculated negative control wells.  
4.2.2 Determination of gene expression 
In order to determine the effect of iron limitation on the coordinate regulation of capsule 
with the complement proteases, the gene encoding a putative transferase cpsE in the 
capsular operon (Lowe et al., 2007) was chosen for study together with scpI and cppA 
under the Fe-limited conditions. For normalization of gene expression, three housekeeping 
genes gyrA, glnA, and sdhA were also included as previously described.  
S. iniae strains QMA0248 and QMA0076 (Aviles et al., 2013) were cultured in Todd-Hewitt 
broth (THB) as described in previous chapter. For iron limitation, THB was supplemented 
with 2,2-dipyridyl (DP) to a final concentration of 1mM. Each strain was cultured in 24-well 
plate with three biological replicates in THB and THB+DP. The sample points were mid-
exponential phase, late exponential phase, and stationary phase. RNA extraction and real-
time PCR procedures followed the protocol described in our previous paper (Chan N. 
Dieu, 2015). Briefly, at each sample point, 1ml subsamples were immediately pelleted at 
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10,000 x g for 2 min at room temperature and re-suspended in 1ml of TRIsure TM (Bioline 
US Inc) and transferred to a 2 ml screw-capped tube containing MagNA Lyser Green 
Beads (Roche Diagnostics, Germany) then homogenized at 7,000 rpm for 40s in a Roche 
MagnaLyser and immediately chilled on ice. The supernatant was transferred into the new 
tube and 200µl chloroform was added. The lysate was shaken vigorously for 15s, 
incubated at room temperature for 2 min then centrifuged at 12,000 x g for 15 min at 40C. 
The aqueous phase was transferred carefully to a new tube, and the RNA was precipitated 
by adding 500 µl of isopropyl alcohol followed by centrifugation at 10,000 x g for 10 min at 
40C. The RNA pellet was washed with 1ml of ethanol 75% and air-dried for 3h. 30 µl of 
DNase- and RNase-free water was added to re-suspend the pellet followed by storing at -
800C for further study. RNA was quantified fluorimetrically using a Qubit fluorimeter (Life 
Technologies, Melbourne) and 20ng per sample was used for cDNA synthesis with the 
QuantiTect® Reverse Transcription Kit (Qiagen®) in accordance with the manufacturer’s 
instructions.  
All real-time PCR experiments were performed in 384 well plates with reagents dispensed 
using an epMotion 5075 Robot (Eppendorf, Hamburg) and thermal cycling was performed 
with the ABI ViiA7 using SYBRGreen Master Mix (Applied Biosystems). The primers and 
input cDNA concentrations were optimized at 200nM and 1ng respectively per reaction to 
yield ~100% efficiency. In each reaction there were 0.2 µl of Forward primer, 0.2 µl of 
Reverse primer (both from 10 µM stock solutions), 5 µl of SYBRGreen Master Mix, 2 µl of 
cDNA 0.5 ng/µl, and 2.6 µl of water. Cycling parameters were: 95 0C for 10 min followed 
by 40 cycles of 95 0C for 15 s and 62 0C for 1 min, then a final melt curve at 950C for 15s, 
600C for 1min and 95 0C for 15 s. All temperature cycling was performed with acceleration 
at 1.6 0C/s. 
4.2.3 Data analysis 
The amplification efficiency was accounted for during normalization of relative gene 
expression differences between the target group and the control group. The normalization 
factor was calculated based on the geometric mean of the relative quantities valued for 
three reference genes using REST (Pfaffl et al., 2002; Vandesompele et al., 2002). Ct data 
were analysed with REST based on the Pair Wise Fixed Reallocation Randomisation Test 
(Pfaffl et al., 2002), in which the normalized relative quantities were calculated based on 
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the ratio of the group means for target gene against the normalized reference genes. The 
result represented the up- or down-regulation of the target groups (i.e. each of the three 
growth phases under iron limitation condition) compared to their respective control group 
(i.e. each of the three growth phases under iron normal condition). Bacterial growth curves 
were analyzed by non-linear regression based on the Gompertz equation (Mytilinaios et 
al., 2012). 
4.3 Results 
4.3.1 Bacterial growth and sampling points 
In order to investigate the coordinate regulation of cpsE and the putative complement 
proteases under the iron limitation condition, the growth curves were constructed for each 
of the bacterial isolates. From the curves potential transition points were identified for 
comparison of gene expression between iron-normal and –limited conditions. Transition 
from log to stationary phase was identified in each curve and samples taken during mid-
log, late-log and stationary phase under iron-normal condition were as the references for 
their corresponding sampling points under iron-limited condition (Figure 17). The 
incubation time points when samples were taken are presented in Table 1.  
 
 
Figure 17. Growth of S. iniae strains (A) QMA0076 and (B) QMA0248 grown under Fe-
normal and Fe-limited conditions 
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Table 1. The sampling time points corresponding to three growth phases under Fe –
normal and –limited conditions 
Strain Condition 
Time cells harvested 
Mid-exponential Late-exponential Stationary 
QMA0076 
Fe-normal 6 h 00 min 9 h 00 min 24 h 00 min 
Fe-limited  13 h 00 min 21 h 00 min 27 h 00 min 
QMA0248 
Fe-normal 5 h 30 min 8 h 50 min 24 h 00 min 
Fe-limited 11 h 00 min 19 h 00 min 27 h 00 min 
 
 
4.3.2 Effect of iron limitation on the coordinate regulation of complement proteases 
and capsule 
The expression of the three genes of interest under iron limitation relative to normal THB 
culture was consistent between strains (Figure 18). During mid log phase, expression of 
cps was significantly up regulated under iron limitation compared to normal THB culture at 
the same point (Figure 18). In contrast scpI was significantly down regulated compared to 
normal THB culture. Expression of cppA was not significantly affected by iron limitation 
during mid- or late- exponential phase in either strain tested (Figure 18), but was 
significantly up regulated during stationary phase under iron limitation compared to growth 
in THB (Figure 18). In contrast, cpsE was significantly down regulated under iron limitation 
compared with THB during stationary phase (Figure 18).  
 
  Effect of Iron Limitation 
 
 [55]  
 
Figure 18. Expression (normalized against three reference genes) of scpI, cppA, and cpsE 
at three growth phases under Fe-limited condition relative to Fe-normal condition. (A) S. 
iniae QMA0076, (B) S. iniae QMA0248 (Mean ± SD, n = 9) 
 
4.4 Discussion 
I investigated the effect of iron limitation as iron is tightly withheld by host high-affinity iron 
binding proteins such as haemoglobin, lactoferrin and transferrin (Cassat and Skaar, 
2013). By comparing gene expression at each growth phase under iron limitation with 
corresponding expression under normal growth in THB relative to normalized reference 
genes I was able to confirm our previous observation that CPS and scpI (and possibly 
cppA) are coordinately regulated (Chan N. Dieu, 2015). Moreover, one of the potential 
inducers of regulation in the host may be the lack of available iron. Free iron in the host is 
extremely limited (Litwin and Calderwood, 1993) and bacteria must employ diverse 
mechanisms in order to free iron, or utilize the host iron-binding compounds directly (Litwin 
and Calderwood, 1993; Neilands, 1981, 1982). Competitive growth and survival inside the 
host requires adaptive responses to iron stress and a number of iron acquisition strategies, 
but is also a signal for the host phase of the lifecycle of pathogenic or commensal 
organisms. The depression of cpsE and consequent capsule depression by S. iniae under 
iron stress may be such an adaptive response. In the blood, capsulated S. iniae causes 
septicaemia, but capsule-deficient mutants preferentially enter CNS instead of remaining 
in blood stream resulting in strikingly different pathology (Millard et al., 2012). It may be 
that depleted iron reserves are a signal that S. iniae has entered the host resulting in 
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immediate up-regulation of the capsule in capsulated strains, allowing rapid dissemination 
through the blood as observed during pathology (usually 24-48 h in warm water fish). 
Subsequently, the capsule is down regulated facilitating attachment, but leaving the 
bacteria potentially exposed to complement. This exposure is ameliorated by relative up-
regulation complement proteases. Further work is required to determine what factors in the 
host may regulate this later switch. 
Nutrient stress in addition to iron stress still occurs when the bacteria life span enters the 
stationary phase (Bacun-Druzina et al., 2011). Therefore it is highly likely that multiple 
interacting factors effect regulation of these systems during growth phase; for example 
elevated CO2, superoxide level, oxygen level, and other metal ions such as zinc or 
manganese (Kreikemeyer et al., 2003). Moreover, there is likely to adaptation to iron 
limited conditions over time as cells activate additional iron acquisition, transport and 
storage systems to better compete with the host for available resources. For example, 
MtsABC transports Fe2+ and Mn2+ in both S. pyogenes and S. agalactiae (Ge et al., 2009), 
iron-binding protein Dpr that required oxygen tolerance in S. mutants (Yamamoto et al., 
2004). In addition, when the Streptococcus gordonii grow in an iron-depleted environment, 
they increase acquisition of Mn2+ (Jakubovics and Jenkinson, 2001; Jakubovics et al., 
2000), and engage the oxidative stress responses (Bsat et al., 1998; Storz and Imlay, 
1999). Oxidative stress from endogenous as well as extracellular sources requires an 
effective defence mechanism. O2!- and H2O2 inside the bacterial cell can cause the 
oxidative damage to the exposed iron sulfur clusters (Imlay, 2008), damage to bacterial 
proteins, DNA, and lipids (Imlay, 2003). Much of this damage is due to iron catalysed 
Fenton chemistry and therefore iron and oxidative stress are tightly linked. However the 
ability of H2O2 to depress the iron uptake system via, for example the PerR regulon, is 
dependent on the iron/manganese ratio within the cell (Faulkner and Helmann, 2011), i.e. 
in the abundant presence of Mn2+, PerR permits uptake iron despite accumulation of H2O2 
(Chen et al., 1995; Fuangthong et al., 2002) because manganese acts as a quencher of 
hydrogen peroxide, helping to protect the cells from oxidative damage (Stadtman et al., 
1990). Also tightly inter-linked with manganese, zinc is the second most abundant metal in 
the host and has the essential role in the immune system (Fischer Walker and Black, 
2004; Rink and Gabriel, 2001). Zinc is released in excess at the mucosal surfaces and can 
be toxic to bacteria (Silver, 1996). Zinc is also known as inducer of the adhesion of 
myelomonocytic cells to the endothelium, which is critical to the recruitment of leukocytes 
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to the infected site (Maret, 2001). Zinc deficiency leads to decreased chemotaxis of 
neutrophils (Maret, 2001). In S. pneumoniae, Zn2+ appears to compete with Mn2+ to bind 
with PsaA, an ATP-binding transporter (Berry and Paton, 1996; McDevitt et al., 2011); 
moreover, binding of Zn2+ to PsaA may be irreversible (McDevitt et al., 2011). The high 
ratio of zinc/manganese leads to restricted growth of S. pneumonia, and increased 
susceptibility to oxidative stress and leukocyte killing (McDevitt et al., 2011). 
Consequently, as the availability of Zn2+ and Mn2+ are intrinsically linked to iron and 
oxidative stress, the factors that regulate complement proteases and capsule need to be 
further investigated under other conditions such as elevated H2O2, and variant 
iron/manganese and zinc ratios.  
In conclusion, I have demonstrated an effect of iron limitation on the coordinate regulation 
of complement proteases and capsule expression in S. iniae. However, this regulation 
appeared to be affected by multiple factors that need to be further investigated. 
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5. Chapter V. Discussion 
5.1 Bacterial strategies to counter the host complement system 
Bacterial pathogens causing septicaemia and meningitis in farm fish, and potentially in 
humans, are extremely diverse, including Gram negative pathogens such as Aeromonas 
hydrophila, Edwardsiella tarda, Erysipelothrix rhusiopathiae, Photobacterium damselae, 
Vibrio spp. to the Gram positives which mainly comprise members of the Streptococci 
(Austin and Austin, 2012). Although different pathogens possess variable pathogenesis 
mechanisms, they share similar basic invasion steps to successfully enter the host, 
including colonization, establishment, compromise of host defences, and host cell and 
tissue damage (Telser, 2002). Pathogens have recruited a variety of strategies to 
overcome the non-phagocytic and phagocytic defence mechanisms including modification 
of membrane receptors to delay host immune recognition, bacterial membrane alteration 
to adapt to antimicrobial peptides, prevention of opsonisation, capsule formation, toxin-
mediated necrosis induction, etc. (Hornef et al., 2002). Successful escape from 
internalization and/or destruction by phagocytes is essential to systemic spread of bacteria 
during blood infection (Hornef et al., 2002), and bacteria have consequently adapted a 
diverse array of mechanisms for phagocyte evasion. For example, Streptococcal 
streptolysin depresses neutrophil chemotaxis during the early stage of S. pyogenes 
infection (Lin et al., 2009). Furthermore, physical prevention of phagocytosis or disguise 
from phagocyte pattern recognition receptors by, for example, polysaccharide capsule, M 
protein and fimbriae as reported in GAS (Urban et al., 2006). In order to escape innate 
humoral factors, the complement proteases directly inactivate the complement system by 
disrupting the essential intermediate components, C5a and C3a, the most potent 
anaphylatoxins that induce the pro-inflammatory response (Yancey and Lazarova, 2008). 
These compelement protein subunits have a pleiotropic effect on the chemoattraction of 
neutrophils, monocytes, macrophages, and T and B lymphocytes (Becker, 1972; El-
Naggar et al., 1980; Snyderman et al., 1975). The disruption of these two C3 and C5 may 
block complement deposition since they are the essential components of C3 convertase 
and C5 convertase complexes, which are integral in the down stream completion of all 
currently understood complement pathways (Yancey and Lazarova, 2008). The C5a 
degrading peptidase, Scp (known as ScpA in S. pyogenes, ScpB in S. agalactiae), is able 
to cleave C5a slowing the influx of polymorphonuclear leukocytes through failure of 
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chemotactic signaling and neutrophil attraction to the infection site (Cleary et al., 2004). 
CppA, the C3 degrading protease, was first characterized in S. pneumoniae and 
completely degrades the α-chain of human C3 protein (Hostetter et al., 2004). The 
disruption of C3 can stop the formation of both C3 and C5 convertase complexes, with 
consequent failure of bacterial opsonisation (Yancey and Lazarova, 2008).  
In spite of the substantial gene loss encountered in marine Streptococci through the 
reductive evolution in comparison to their terrestrial counterparts, putative homologues of 
the proteins are present in the genomes of S. iniae (Baiano and Barnes, 2009), and are of 
interest as potentially important virulence factors and therefore formed the basis of 
investigation in this thesis. First, I established a strong informatics basis for their putative 
roles as secreted complement-degrading proteases: I identified signal peptides and 
cleavage sites using Signal P4.1 (Nielsen et al., 1999b) and ProParam confirming likely 
direction of ScpI to the secretion pathway: ScpI possesses a putative twin arginine at 
residues 32 and 33, while it is at residue 31,32 in ScpA (Chen and Cleary, 1990). 
Subsequently, the putative proteolytic active site and metal binding domains were 
identified with Phyre2 (Sternberg and Kelley, 2009). There is also a S8 peptidase domain 
highly homologous with ScpA along with the active cleavage site triad at residues Asp114, 
His181 and Ser501, while those residues in ScpA and ScpB are Asp130, His193 and 
Ser512 or Ser509 (Chen and Cleary, 1990; Siezen et al., 1991). Streptococcus iniae CppA 
is highly homologous to the CppA N-terminal domain in S. pyogenes and C3-degrading 
protease in S. dysgalactiae. However there was neither detectable signal peptide nor 
predictable transmembrane helices, or beta barrel or membrane anchor.  Teleost fish 
possess a potent complement system and functional complement protein homologues 
(Boshra et al., 2006; Holland and Lambris, 2002). The cytolysis and opsonisation for later 
phagocytis have been confirmed in a wide range of fish (Byon et al., 2006; Gonzalez et al., 
2007; Nonaka et al., 1985; Sakai, 1984). However, the fish complement proteins do 
possess many structural isoforms which may be transcribed from more than one gene 
(Holland and Lambris, 2002). Indeed, the genes encoding for C3 in fish are polymorphic 
and may need multiple mechanisms to activate (Jensen and Koch, 1991; Nonaka et al., 
1985). Therefore, while ScpI is a potential candidate for C5a cleaving protease in fish, 
CppA requires some further investigation, particularly in light of its lack of tat pathway 
secretion or signal peptide and consequently its predicted cytoplasmic location. 
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Fish pathogens may target the complement system in at other points in the pathway. For 
example, in Neisseria meningitidis, NalP protease can cleave both C3 and C4 (Tordello et 
al., 2014); the PgtE protease of Salmonella enterica is able to cleave C3b, C4b, and C5 to 
facilitate the serum resistance (Ramu et al., 2007); the Alp1 protease in Aspergillus 
fumigatus is an effective protease that can cleave a variety of complement proteins, i.e. 
C1q, C3, C4, C5, and also IgG (Behnsen et al., 2010). This multiple function property can 
also be found in Group A Streptococci SpeB protein. Mature SpeB can cleave the C3 
component and prevent the formation of the C5 convertase complex (Kuo et al., 2008; 
Terao et al., 2008), lyse Properdin leading to a labile complex subsequently been 
inactivated (Tsao et al., 2006). Furthermore, isogenic ∆speB mutants cause lower mortality 
and tissue damage than the wild type (Lukomski et al., 1997). SpeB cysteine protease is 
also involved in the damage of mitochondrial of polymorphonuclear cells that help S. 
pyogenes escape from phagocyte clearance at the early infectious stage (Chiang-Ni et al., 
2006). SpeB may also selectively cleave antibodies at the hinge region once they bind to 
antigens on the surface of S. pyogenes (Söderberg et al., 2008). Furthermore, this 
protease can also hydrolyse and destroy chemokines, which are secreted by inflamed 
epithelial cells, and are responsible for signalling and antibacterial activity (Egesten et al., 
2009). SpeB can also induce inflammation by cleaving pro-interleukin-1β into active form 
interleukin-1β (Kapur et al., 1993a), hydrolysing H-kininogen into bradykinin (Herwald et 
al., 1996), inducing histamine release and mast cells degranulation (Watanabe et al., 
2002), which enhances S. pyogenes infection. It is likely SpeB is an important part of the 
multi-target invasion strategy of S. pyogenes as it effectively degrades innate immune 
barriers including fibrin/fibrinogen in blood coagulation (Elliott, 1945; Matsuka et al., 1999), 
antigen-bound plasmin (Svensson et al., 2002), extracellular matrix proteins vitronectin 
and fibronectin (Kapur et al., 1993b); and indirectly participates in tissue degradation and 
apoptosis (Burns et al., 1996; Tamura et al., 2004). The multiple roles of SpeB in the 
virulence of terrestrial Streptococcal strains merit further investigation of additional roles 
for scpI in S. iniae and searching the genome for alternative potential C3-degrading 
protease. 
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5.2 Relationship between growth phase and gene expression 
During the bacterial life span, a typical growth curve has four stages: lag phase, 
exponential growth phase, stationary phase, and finally, death phase (Bell, 2000). There 
are few studies of lag phase, but it is assumed to be an adaptation phase before entering 
a new environment that allows bacterial self-reparation e.g. macromolecular damage 
during previous stationary phase or dormancy (Dukan and Nyström, 1998; Madigan, 
2015). Exponential phase is when the cells divide with an exponential rate and requires a 
large amount of nutrient including carbon, nitrogen, phosphate, and trace elements such 
as iron (Madigan, 2015). During this expansion phase synthesize a large amount of DNA, 
along with proteins and their regulators are synthesized (Madigan, 2015). As a variety of 
stresses such as nutrient, density, toxin, waste, etc. accumulate, bacteria enter stationary 
phase where the rate of accumulation of new cells is equal to the death rate (Madigan, 
2015). Indeed, in the natural environment, particularly in the host, where the nutrient such 
as trace elements are usually withheld as a host defence strategy, the bacteria are often 
found in starvation conditions until infection progresses sufficiently for bacterial toxins to 
release nutrients from degraded or necrotic tissue (Bacun-Druzina et al., 2011). Therefore 
pathogenic bacteria have to undergo a number of morphological and physiological 
changes as an adaptive response on host entry (Zinser and Kolter, 2004). The effect of 
growth phase on gene expression has been studied for decades, and it is one of the 
critical mediators of environment-dependent change of bacterial protein expression 
(McIver and Scott, 1997; Unnikrishnan et al., 1999). In order to adapt to the known or 
unknown new environment, the bacteria expresses some core proteins that they continue 
to produce from the previous environment, along with a range of adaptive proteins 
including virulence factors that help them to survive in the new niche or host (Smoot et al., 
2001a; Unnikrishnan et al., 1999). The array of genes involved in mediating and executing 
the adaptive strategies are expressed dependent on stage of bacterial growth and on 
conditions in the environment around them, so called growth phase regulation (Barnett et 
al., 2007; Hornef et al., 2002). For example, the expression of virulence gene regulator 
mga in S. pyogenes is maximal in the exponential phase and is shut down in the stationary 
phase, along with Mga-regulated genes scpA and emm, in order to save energy under 
starvation condition (McIver and Scott, 1997). Moreover, the expression of toxin genes is 
delayed to rescue the bacteria in stressful conditions. For example, Streptococcal 
pyrogenic exotoxin A speA from S. pyogenes is a phage-encoded toxin (Weeks and 
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Ferretti, 1986) and its expression is delayed until the late log phase; Streptococcal 
pyrogenic exotoxin B speB is only expressed under starvation or stressful conditions 
(Chaussee et al., 1997); no detectable SpeB is expressed in antibiotic-free or high nutrient 
medium as detected by Northern blot hybridization (LeBlanc et al., 1986). With the clear 
evidence of growth phase regulation of virulence genes in Streptococcal pathogens, it is a 
reasonable starting point for investigating coordinate regulation of complement proteases 
with capsule expression.  
5.3 The coordinate regulation of complement proteases and capsule 
In chapter two, I demonstrated the coordinate regulation of complement protease 
expression with CpsE expression in late exponential phase. In Streptococci, 
polysaccharide capsule is considered the major virulence factor which varies depending 
on serotype (Lowe et al., 2007). The variation of capsule from group B Streptococcus 
helps to reduce the C3b opsonisation (Martins et al., 2010). In S. iniae, the expression of 
capsule has been demonstrated necessary for infection (Miller and Neely, 2005) in a 
zebrafish model. Interestingly, the capsule deficient variants of S. iniae preferably entered 
the spinal column of barramundi, but do not cause the characteristic septicaemia and 
meningitis (Millard et al., 2012). In addition, capsule is unnecessary for the colonization by 
S. pneumoniae of bronchoepithelial cells (Magee and Yother, 2001; Morona et al., 2004). 
Moreover, an uncapsulated isolate of S. pneumonia had higher invasive capacity than the 
capsulated isolate (Adamou et al., 1998), suggesting the possibility the cps expression 
may impede attachment to an invasion of cells. Therefore, the coordination of cps 
expression with complement proteases scpI and cppA may be a sound pathogenesis 
strategy to maintain complement resistance during attachment to host cells for subsequent 
tissue invasion. I chose cpsE as a gene in the capsular operon immediately downstream of 
the regulatory complex of cpsABCD, and identified previously as a possible priming 
glycosyl transferase required for cps expression (Lowe et al., 2007). Gene expressions 
were determined at each growth phase, and the coordinate regulation of scpI and cppA 
with cpsE occurred in the late exponential phase. In all three growth-phases, the 
expression of scpI was more dramatically changed than the cppA. The susceptibility of S. 
iniae wild type isolates over the growth phases was investigated by whole blood 
bactericidal assay and indicated higher susceptibility of S. iniae to whole blood during late 
log phase, when capsule is down regulated. This result was consistent with the previous 
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study that a capsule-deficient isolate was susceptible to whole blood (Locke et al., 2007; 
Lowe et al., 2007). The results are also consistent with my hypothesis that capsule must 
be down-regulated to allow adherence which may be required for progression of the 
disease from the blood to the CNS. This was further corroborated by the plastic adherence 
assay in which the late log inoculum was the most adherent; indeed, capsule has been 
reported to impede adherence (Magee and Yother, 2001; St Geme and Falkow, 1991).  
To tease apart the respective roles of neutrophils and plasma factors such as complement 
in the inhibition of growth and therefore potential roles for ScpI and CppA proteases. I 
challenged inocula in each of the three growth phases in a serum killing assay with heat-
inactivated (HI) serum supplemented with or without specific antibodies and fresh serum 
as a source of complement proteins and other heat labile plasma proteins. The resistance 
to serum killing generally declined over the growth phase, with the exception of resistance 
to HI specific anti-serum supplemented with fresh serum where the late log inoculum was 
resistant/survived at a similar level to the mid log inoculum. Surprisingly, the general 
resistance/survival of these two inocula in the HI specific anti-serum with added fresh 
serum (HIAS+FS) as a source of complement significantly increased compared to the HI 
specific anti-serum alone. While the HI normal serum supplemented with fresh serum 
(HINS+FS) was established as a model where the lectin and alternative pathways are 
active, the HI specific anti-serum with added fresh serum should also have active classical 
pathway. The higher survival of late log inoculum in the HIAS+FS may reveal the 
involvement of scpI and cppA in resistance to or subversion of the classical pathway, as 
well as their protective role when cpsE is down regulated. However, taken together with 
the results from whole blood killing assay, the up-regulation of the complement proteases 
in late log phase did not fully protect the bacteria. The down regulation of cpsE resulting in 
the ineffective capsule (Doran et al., 2005; Lowe et al., 2007) can facilitate the successful 
adherence (St Geme and Falkow, 1991) in the late log phase. However, the complement 
degrading mechanism is not the only strategy in this circumstance. The evidence is the 
late log phase inoculum was still significantly killed (50%) in the whole blood, where 
neutrophils are likely the major means of bacterial neutralisation. In order to clarify the role 
of scpI and cppA in S. iniae virulence, isogenic knock out mutants of these genes were 
prepared and reveal their multiple functions in growth and survival.  
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5.4 The pleiotropic effect of complement proteases 
In chapter three, I explored the phenotype of knock out (KO) mutant ΔscpI and ΔcppA and 
found them more susceptible compared to the wild type to host innate immunity in vitro 
regardless the growth phases. In a previous study virulence of ΔscpI was investigated in a 
hybrid stripped bass challenge model and there was no attenuation (Locke et al., 2008). 
This IP- and IM-injection route might ignore the role of scpI in the early stage of infection 
from the environment. Furthermore, the inactivation of this gene does not always lead to 
the general reduction in virulence in vivo. In a mouse challenge model, ΔscpA of S. 
pyogenes was no different to wild type in the incidence of throat colonization, however 
there was a decrease of incidence of pneumonia caused by ΔscpA (Husmann et al., 
1997). In Streptococcal species, the complement proteases appeared to be multi-
functional in pathogenesis. Besides the ability to cleave and inactivate C5a, Scp can act as 
an adhesin to Fibronectin III due to the induced conformational change of Fn and enhance 
the invasion of non-phagocytic cells (Beckmann et al., 2002; Hull et al., 2008). The 
presence of recombinant ScpA peptidase from S. pyogenes delayed the recruitment of 
polymorphonuclear leukocytes in a mouse IP challenge model. However, there was no 
difference in virulence between ΔscpA and wild type by IP injection in vivo (O'Connor and 
Cleary, 1987). There is evidence of delay of polymorphonuclear leukocyte recruitment to 
the infection site and chemokine impairment by ScpA and ScpC in GAS (Belotserkovsky et 
al., 2006) and in GBS (Bohnsack et al., 1993). Although knockout mutants resulted in no 
effect on mortality in a mouse model (Belotserkovsky et al., 2006; Ji et al., 1996), ΔscpA 
and wild-type followed different paths for dissemination within the infected mice, i.e. ΔscpA 
translocated into the lymph nodes, while the wild type preferentially occurred in the spleen 
(Ji et al., 1996).  
The C3-degrading protease SpeB in GAS can interact with diverse molecules to block 
immune functions e.g. cleave antibodies (Söderberg et al., 2008), destroy chemokines 
(Egesten et al., 2009), cleave pro-interleukin-1β into active form interleukin-1β (Kapur et 
al., 1993a), hydrolyze H-kininogen into bradykinin (Herwald et al., 1996) which enhances 
GAS infection. In chapter three, this pleiotropic effect may be evident via the phenotypes 
of the protease knock out mutants when they were exposed to whole blood and sera: they 
were not only more susceptible compared to the wild type, but also had restricted growth 
rates. I also observed these complement proteases were not involved directly in resistance 
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to either the lectin or the alternative complement pathways. However, with the addition of 
fresh serum to heat-inactivated specific antiserum to activate the classical pathway, I 
observed the mid-log inoculum of both mutants was significantly killed rather than the late-
log inoculum. This result may reflect the fact that there is a basal expression of 
complement proteases during down regulation in the mid-log phase, but the knockout of 
the protease expression in the mutants apparently increases their susceptibility to blood 
killing and also impacts their growth. It is highly likely that ScpI and/or CppA either 
contribute in the modification of the bacterial cell surface to reduce the antibody cross-
reactivity, or interact with antibody preventing binding to activate the classical pathway. For 
example, polyclonal antibody in rabbit anti-ScpB serum did not function as an opsonin to 
facilitate the association of macrophage and GBS, however it enhanced the killing activity 
of the macrophage by promoting the anti-Cps antibody (Cheng et al., 2001). Interestingly, 
the induced specific antibody which was directly against ScpB was not only opsonic but 
also reduced the colonization of GBS (Cheng et al., 2001) and inhibited the invasion of 
GBS into the epithelial cells (Cheng et al., 2002). It is likely that the conjugation ScpB-Cps 
induces a strong response of functional antibody and enhances the bactericidal activity of 
macrophage. Therefore, the conjugation ScpB-Cps sounds promising for vaccine 
production (Cheng et al., 2001).  
Bacteria can take advantage of host complement regulatory factors to help them interfere 
with these pathways. For example, in our serum-killing assay, the survival and slight 
resistance of the knock out mutants in HINS+FS (with complement activity) may be due to 
factor H activity. Factor H, a co-factor for factor I, is an essential regulator of the alternative 
pathway (Müller-Eberhard and Schreiber, 1980). Factor H can bind to the Streptococcal M 
protein to protect them from the alternative pathway (Giannakis et al., 2003). This binding 
prevents the formation of C3 convertase (Jones and Fischetti, 1988) as well as dissociates 
factor B from C3- and C5-convertases (Lars et al., 2002). Furthermore, factor H can bind 
to Mac-1 which is the integrin promoting neutrophil response (DiScipio et al., 1998). The 
remaining factor H in the heat-inactivated sera might help the KO mutants escape from the 
neutrophil-mediated killing. Therefore, the activity of recombinant ScpI and CppA should 
be investigated against a wide range of complement regulators and antibodies. Moreover, 
a dual knock out should be studied to determine the interaction between these two 
proteases as well as amongst the intermediates of the complement cascade.  
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5.5 The effect of iron limitation on complement proteases and capsule expression 
During bacterial growth, the environmental conditions change substantially over the growth 
phases, as toxins accumulate and nutrients are converted and depleted (Madigan, 2015). 
The diverse environmental effects encountered through growth phase act upon a wide 
range of regulatory mechanisms within the cells and make growth phase an excellent set 
of conditions for investigating coordinate gene regulation. For example, the membrane 
lipid composition and the virulence gene RpoS/RpoH expression in Salmonella Enteritidis 
had coordinately regulated in order to adapt to lethal heat and lactic acid stress (Yang et 
al., 2014); in Staphylococcus aureus, O2 and NO act as an environment cues that induce 
the regulated expression of variety of virulence genes including T3SS, HlyE, LukD, TSST1 
(Green et al., 2014); the dynamic expression of operon flhDC which is responsible for 
flagella in Salmonella enterica is growth phase dependent, and is regulated by either LrhA 
or RcsB in different stages of growth (Mouslim and Hughes, 2014). Consequently, I was 
able to document inverse coordinate regulation of scpI and cppA with cpsE in the capsular 
operon. However, the key environmental triggers that drive this regulation in the host 
during colonization remain to be elucidated. In order to adapt to and escape from the host 
defence, diverse mechanisms are recruited and these mechanisms require availability of 
essential nutrients such as iron (Bacun-Druzina et al., 2011). Therefore, limited nutrient 
conditions act as a signal for launching an adaptive mechanism to this environment 
(Hornef et al., 2002). Therefore I investigated the expression of scpI and cppA under iron 
limitation compared to standard culture media, since the availability of iron is extremely 
limited during infection due to tight withholding by the host high-affinity iron binding 
proteins (Cassat and Skaar, 2013). Competitive survival in the host requires the invading 
pathogen to be adaptively responsive to iron stress. I found that cpsE, consequently 
capsule, is down regulated under iron stress and this may be an adaptive response. The 
depletion of iron may serve as a signal for immediate up-regulation of the capsule allowing 
rapid dissemination in the blood stream.  The down regulation of capsule in the next 
growth phase followed by the relative up regulation of complement proteases may 
enhance the adherence whilst maintaining some protection against host innate immune 
factors. However which factor triggers this depression is still unknown. The limitation of 
iron is also linked with Mn2+ acquisition (Jakubovics and Jenkinson, 2001), the oxidative 
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stress responses (Bsat et al., 1998; Storz and Imlay, 1999), and the availability of Zn2+ 
(McDevitt et al., 2011). Furthermore, even in rich culture media, nutrient stress still occurs 
when the bacteria transform to the next phase in their lifecycle (Bacun-Druzina et al., 
2011) and a large number of virulence factors involved in the interaction between host and 
pathogen is expressed under the control of transcriptional regulators that respond to these 
kinds of environmental signals (Kreikemeyer et al., 2003).  
Two-component signal transduction is a frequently employed mechanism in GAS that links 
host-environment signals with the bacterial adaptive response, i.e. the transcriptional 
regulator is triggered by a phosphoryl group pre-stimulated by a sensor histidine kinase as 
the response to the host signal (Hoch, 2000). Furthermore, this interaction is also 
controlled by multigene regulons such as the Mga regulon in GAS (Caparon and Scott, 
1987). In GAS, scpA is regulated by the Mga regulon, which is a growth-phase dependent 
regulator that maximizes its expression in the exponential phase (Kreikemeyer et al., 
2003), and is sensitive to the increase of carbon dioxide, iron starvation and increased 
temperature (Caparon et al., 1992; Kreikemeyer et al., 2003; McIver et al., 1995). Mga 
regulates a cluster of virulence genes being responsible for entry, colonization and 
immune invasion including emm, scpA, sof, rofA, speB etc. and mga itself (Mühldorfer and 
Schäfer, 2001). The homologous regulator to Mga in GAS has been found in S. iniae 
called Mgx (Baiano et al., 2008), which is 20-fold increased in expression in the 
exponential phase under iron limited condition (Aviles et al., 2013). Mgx is the regulator of 
SiMA, the M-like protein found in S. iniae, and correlatively expressed with SiMA in the 
exponential growth phase when iron was limited (Aviles et al., 2013). Interestingly, the 
adding of fresh serum which contained labile humoral factors such as complement 
proteins and fibrinogen reduced the phagocytosis and oxidative burst of barramundi 
leucocytes (Aviles et al., 2013). Therefore, the gradual increase of scpI and cppA 
expression over the growth phases under iron-limited condition (chapter four) supports the 
reduction of phagocytosis in Aviles’s experiment. Indeed, S. iniae does not possess the 
GAS-like Mga locus (Locke et al., 2008) containing mga, emm, and scpA in the regulon. 
Rather the mga-like mgx is located adjacently upstream of the emm-like simA, the scpI 
locates at the different locus in the genome and does not possess the upstream promoter 
region like scpA does for Mga in GAS (Locke et al., 2008). Therefore, the regulator of scpI 
and whether it is sensitive with iron limitation like mga is still unknown. Since the 
environmental cues and the growth phase related signals significantly influence bacterial 
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virulent gene expression, the expression of scpI and cppA is worth further investigation in 
different stress conditions. 
In conclusion, I have demonstrated the influence of the growth phase on the expression of 
two complement proteases ScpI and CppA, and their coordinate regulation with CpsE, in 
the capsular operon in S. iniae. However which environmental and/or growth phase related 
signals that trigger this regulation are unknown. I also demonstrated that ScpI and CppA 
might be involved in interference with the classical complement pathway through the 
susceptibility of the knock out mutants to antiserum in the presence of complement. 
However, completely deleting these proteases revealed pleiotropic effects, which included 
bacterial growth as well as innate immune resistance, which suggests complicated multiple 
roles in pathogenesis and survival. These pleiotropic roles coupled with the understanding 
of the regulation of these proteins demonstrated in this thesis suggests that they are good 
candidates for conserved protein vaccine targets, and can be up-regulated during culture 
potentially improving potency and longevity of killed cell vaccines. 
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Appendix A 
 
Figure 19. Growth of S. iniae QMA0248 and S. iniae QMA0076 in Todd-Hewit Broth 
 
 
Table 2. Sampling time points of S.iniae strains grown in Todd-Hewit Broth 
 
Strain Time cells harvested 
Mid-exponential Late-exponential Stationary 
QMA0076 6 h 00 min 9 h 00 min 24 h 0 min 
QMA0248 5 h 30 min 8 h 50 min 24 h 0 min 
 
Appendix B 
Table 3. Primer sequences for fusion PCR to generate knock-out insertion 
 
No. Primers Sequences 5’-3’ Length GC% Tm 
Amplicon 
(bp) 
1 F1-scpi TGGGGTTGTTAACGTTGGTCT 21 47.62 59.79 
1058 
2 R1-scpi ATTCAAATATATCCTCCTCAATATATTCCTCCAATAGAT 39 28 69.4 
3 F3-scpi AAACTATTTAAATAACAGATTATCAAAAAAGAATGTTCGCCT 42 24 69.2 
1058 
4 R3-scpi TTGCTGAGAGTTATGGCGCA  
 
20 50 60.04 
5 F-all-scpi AGCAACACCTTGGTTAGCAGT 21 47.62 60.13 
2544 
6 R-all-scpi TTGCAGCTTACTACCGCTCT 20 50 59.10 
7 F1-cppa ACTTTCCATCAAGGCATCACG 21 48 59.5 917 
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 [95]  
8 R1-cppa ATTCAAATATATCCTCCTCCATTACCTCTTTTTGACCTCA 40 35 72.8 
9 F3-cppa AAACTATTTAAATAACAGATTGGTTTCCTCCTAACCTCT 39 31 70.6 
1016 
10 R3-cppa CTGAATAGGGCTTGCGCTGA  
 
20 55 60.5 
11 F-all-cppa AGCCGCTTCTTGCTTATTGTTT 22 40.91 59.44 
2428 
12 R-all-cppa CACTGACAATGCCGGCAAAA 20 50 58.4 
13 F2-aad9 GAGGAGGATATATTTGAATACATACG 26 35 61.7 
753 
14 R2-aad9 AATCTGTTATTTAAATAGTTTATAGTTA 28 14 55.4 
 
